Section 47

EurekaMag Full Text Articles Chapter 46,144


Cousins, L.M. 1994: GDM screening. Journal of Family Practice 38(6): 568-569
Bonde, C.; Kristensen, B.W.; Blaabjerg, M.; Johansen, T.E.; Zimmer, J.; Meyer, M. 2000: GDNF and neublastin protect against NMDA-induced excitotoxicity in hippocampal slice cultures. Neuroreport 11(18): 4069-4073
Martucciello, G.; Thompson, H.; Mazzola, C.; Morando, A.; Bertagnon, M.; Negri, F.; Brizzolara, A.; Rocchetti, L.; Gambini, C.; Jasonni, V. 1998: GDNF deficit in Hirschsprung's disease. Journal of Pediatric Surgery 33(1): 99-102
Sinclair, S.R.; Svendsen, C.N.; Torres, E.M.; Martin, D.; Fawcett, J.W.; Dunnett, S.B. 1996: GDNF enhances dopaminergic cell survival and fibre outgrowth in embryonic nigral grafts. Neuroreport 7(15-17): 2547-2552
Strelau, J.; Unsicker, K. 1999: GDNF family members and their receptors: expression and functions in two oligodendroglial cell lines representing distinct stages of oligodendroglial development. Glia 26(4): 291-301
Bickford, P.C.; Bowenkamp, K.; Taglialatela, G.; Hoertig, G.; Granholm, A.C. 2001: GDNF improves cerebellar Purkinje neuron function in aged F344 rats. Microscopy Research and Technique 54(5): 309-316
Lindsay, R.M.; Yancopoulos, G.D. 1996: GDNF in a bind with known orphan: accessory implicated in new twist. Neuron 17(4): 571-574
Beck, K.D.; Irwin, I.; Valverde, J.; Brennan, T.J.; Langston, J.W.; Hefti, F. 1996: GDNF induces a dystonia-like state in neonatal rats and stimulates dopamine and serotonin synthesis. Neuron 16(3): 665-673
Giehl, K.M.; Schacht, C.M.; Yan, Q.; Mestres, P. 1997: GDNF is a trophic factor for adult rat corticospinal neurons and promotes their long-term survival after axotomy in vivo. European Journal of Neuroscience 9(11): 2479-2488
Mitsumoto, H. 2000: GDNF is trophic for mouse motoneurons that express a mutant superoxide dismutase (SOD1) gene. Amyotrophic Lateral Sclerosis and other Motor Neuron Disorders: Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 1(2): 69-70
Arenas, E.; Trupp, M.; Akerud, P.; Ibáñez, C.F. 1995: GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo. Neuron 15(6): 1465-1473
Saarma, M. 2001: GDNF recruits the signaling crew into lipid rafts. Trends in Neurosciences 24(8): 427-429
Arenas, E. 1996: GDNF, a multispecific neurotrophic factor with potential therapeutic applications in neurodegenerative disorders. Molecular Psychiatry 1(3): 179-182
Hiwasa, T.; Kondo, K.; Hishiki, T.; Koshizawa, S.; Umezawa, K.; Nakagawara, A. 1997: GDNF-induced neurite formation was stimulated by protein kinase inhibitors and suppressed by Ras inhibitors. Neuroscience Letters 238(3): 115-118
Gille, A.; Wenzel-Seifert, K.; Doughty, M.B.; Seifert, R. 2003: GDP affinity and order state of the catalytic site are critical for function of xanthine nucleotide-selective Galphas proteins. Journal of Biological Chemistry 278(10): 7822-7828
Dean, F. 1998: GDS funding and NHS dentistry. British Dental Journal 184(8): 369
Miglior, S. 2002: GDx in glaucoma. Acta Ophthalmologica Scandinavica. Supplement 236: 36-40
Anonymous 1997: GE HiSpeed advantage computed tomography scanner. Health devices 26(12): 457-470
Wagner, M. 1991: GE Medical, R Squared settle suits. Modern Healthcare 21(10): 16
Kuntz, E. 1980: GE buys EMi CT scanner business. Modern Healthcare 10(6): 12
Beckers, C. 1999: 131i therapy of toxic and non-toxic goiters. Quarterly Journal of Nuclear Medicine: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology 43(4): 291-296
Freiherr, G. 1997: GE finds national stage for digital mammography. Diagnostic Imaging 19(8): 69
Hensley, S. 1998: GE settles with feds. Competition increased for medical equipment service. Modern Healthcare 28(29): 22
Lerner, D.J.; Galvin, R.S.; Buck, C.R. 1993: GE sheds light on managed care's impact on health. Business and Health 11(9): 48; 50 52-54
Nemes, J. 1991: GE tax-exempt lease plan saves time, money. Modern Healthcare 21(46): 44
Zuurmond, A.M.; Martien de Graaf, J.; Olsthoorn-Tieleman, L.N.; van Duyl, B.Y.; Mörhle, V.G.; Jurnak, F.; Mesters, J.R.; Hilgenfeld, R.; Kraal, B. 2000: GE2270A-resistant mutations in elongation factor Tu allow productive aminoacyl-tRNA binding to EF-Tu.GTP.GE2270A complexes. Journal of Molecular Biology 304(5): 995-1005
Sakai, Y.; Yoshida, T.; Tsujita, T.; Ochiai, K.; Agatsuma, T.; Saitoh, Y.; Tanaka, F.; Akiyama, T.; Akinaga, S.; Mizukami, T. 1997: GE3, a novel hexadepsipeptide antitumor antibiotic, produced by Streptomyces sp. I. Taxonomy, production, isolation, physico-chemical properties, and biological activities. Journal of Antibiotics 50(8): 659-664
Wang, J.-P. 2003: GEA3162 stimulates Ca2+ entry in neutrophils. European Journal of Pharmacology 458(3): 243-249
Hall, E.T.; Weaver, K.W.; Perino, A.C.; Elder, A.; Verghese, A. 2018: 'A man Walks into a Bar': Riddles in the Teaching of Medicine. American Journal of Medicine 131(9): 1000-1002
Franco-Paredes, C.; Mathur, S.; Villamil-Gomez, W.; Henao-Martínez, A.és.F. 2018: A man who Harvest Peanuts with Verrucous Lesions in his Right Index Finger. American Journal of the Medical Sciences 355(3): E7
Geyer, M.; Wittinghofer, A. 1997: GEFs, GAPs, GDIs and effectors: taking a closer (3D) look at the regulation of Ras-related GTP-binding proteins. Current Opinion in Structural Biology 7(6): 786-792
Sprang, S. 2001: GEFs: master regulators of G-protein activation. Trends in Biochemical Sciences 26(4): 266-267
Al-Arashi, W.; Geijteman, E.C.T.; Schweitzer, D.H. 2018: A man who was unable to open his eyes. Nederlands Tijdschrift Voor Geneeskunde 162: D2176
Ono, M. 2002: GEM (glycosphingolipid enriched microdomain) and cancer. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 47(4 Suppl): 365-370
Zoli, A.; D'Agostino, M.A.; Pompa, A.; Altomonte, L.; Mirone, L.; Magarò, A. 1999: Failure of aggressive anticoagulant therapy in catastrophic antiphospholipid syndrome. Clinical and Experimental Rheumatology 18(1): 113
Shiffman, R.N.; Karras, B.T.; Agrawal, A.; Chen, R.; Marenco, L.; Nath, S. 2000: GEM: a proposal for a more comprehensive guideline document model using XML. Journal of the American Medical Informatics Association: Jamia 7(5): 488-498
Sham, P.C.; Sterne, A.; Purcell, S.; Cherny, S.; Webster, M.; Rijsdijk, F.; Asherson, P.; Ball, D.; Craig, I.; Eley, T.; Goldberg, D.; Gray, J.; Mann, A.; Owen, M.; Plomin, R. 2000: GENESiS: creating a composite index of the vulnerability to anxiety and depression in a community-based sample of siblings. Twin research: the official journal of the International Society for Twin Studies 3(4): 316-322
Friedman, C.; Kra, P.; Yu, H.; Krauthammer, M.; Rzhetsky, A. 2001: GENIES: a natural-language processing system for the extraction of molecular pathways from journal articles. Bioinformatics 17 Suppl. 1: S74-S82
Gupta, S.K.; Ghosh, T.C. 1996: GENOLYTE: a PC-based computer program for visualisation of genomic DNA sequences. Indian Journal of Biochemistry and Biophysics 33(2): 152-155
Melani, A.S.; Sestini, P.; Aiolfi, S.; Barbato, N.; Canessa, P.; De Angelis, G.; Zanchetta, D.; De Tullio, R.; Cinti, C.; Neri, M. 2001: GENebu Project: home nebulizer use and maintenance in Italy. European Respiratory Journal 18(5): 758-763
Cowling, E.B.; Kelman, A.; Powers, H.R. 1999: George Henry Hepting: Pioneer Leader in Forest Pathology. Annual Review of Phytopathology 37: 19-28
Dobashi, K. 2001: GERD (gastroesophageal reflux disease). Nihon Rinsho. Japanese Journal of Clinical Medicine 59(10): 2045-2050
Kinoshita, Y.; Adachi, K.; Ishihara, S. 2002: GERD after H. pylori eradication therapy. Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 2): 477-482
Falk, G.W. 2001: GERD and H. pylori: is there a link?. Seminars in Gastrointestinal Disease 12(1): 16-25
Spechler, S.J. 2000: GERD and its complications. Mount Sinai Journal of Medicine new York 67(2): 106-111
Pisegna, J.R. 2001: GERD and its complications. the pathogenic relationship between symptoms and disease progression. Postgraduate Medicine Spec No: 19-23
Kuritzky, L.; Rodney, W.M. 2001: GERD management. Strategies recommended for primary care practice. Postgraduate Medicine Spec No: 11-18
Tytgat, G.N. 2001: GERD remains an intriguing enigma. Gastroenterology 120(4): 787
Sharma, P.; Sampliner, R. 1997: GERD, DGER, or both in Barrett's esophagus?. American Journal of Gastroenterology 92(5): 903-904
Williams, C.N. 1999: GERD--what is this?. Canadian Journal of Gastroenterology 13(7): 552
Hongo, M.; Tamura, D. 2002: GERD/reflux esophagitis. Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 2): 608-613
Anonymous 2000: GERD: more than just heartburn. Harvard Men's Health Watch 4(8): 1-4
Kim, Y.K.; Lee, H.W.; Son, K.H.; Kwon, B.M.; Jeong, T.S.; Lee, D.H.; Shin, J.; Seo, Y.; Kim, S.U.; Bok, S.H. 1996: GERI-BP002-A, novel inhibitor of acyl-CoA: cholesterol acyltransferase produced by Aspergillus fumigatus F93. Journal of Antibiotics 49(1): 31-36
Gatell, J.M.; Blanco, J.L.; Alcamí, J.; Antela, A.; Arrizabalaga, J.; Casado, J.L.; Clotet, B.; Delgado, R.; Erice, A.; Guerra, L.; Guerrero, A.; Iribarren, J.A.; Leal, M.; López, J.C.; Menéndez-Arias, L.; Miró, J.M.; Moreno, S.; Pérez, J.L.; Pumarola, T.; Rubio, R.; Ruiz, L.; Santamaría, J.M.; Soriano, V.; Telenti, A.; Viciana, P. 2001: GESIDA Consensus document on the use of resistance studies in clinical practice. Enfermedades Infecciosas y Microbiologia Clinica 19(Monografico): 53-60
Miró, J.M.; Arrizabalaga, J.; Gatell, J.M. 1998: GESIDA survey on antiretroviral treatment in 1998. Working Group for the Study of AIDS (GESIDA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). Enfermedades Infecciosas y Microbiologia Clinica 16 Suppl. 1: 69-70
Miralles, P.; Rubio, C.; Berenguer, J.; Ribera, Jé.María.; Calvo, F.; Diaz Mediavilla, Jín.; Diez-Martín, Jé.Luis.; López Aldeguer, Jé.; Valencia, E.; Rubio, R.; Felipe, C. 2002: GESIDA/PETHEMA guidelines for the diagnosis and treatment of lymphomas in HIV-infected patients. Medicina Clinica 118(6): 225-236
Hunter, L.; Taylor, R.C.; Leach, S.M.; Simon, R. 2001: GEST: a gene expression search tool based on a novel Bayesian similarity metric. Bioinformatics 17(Suppl 1): S115-S122
Dennstedt, F.E. 2001: GEWF solution. Archives of Pathology and Laboratory Medicine 125(11): 1415
Sakai, Y.; Yoshida, T.; Ochiai, K.; Uosaki, Y.; Saitoh, Y.; Tanaka, F.; Akiyama, T.; Akinaga, S.; Mizukami, T. 2002: GEX1 compounds, novel antitumor antibiotics related to herboxidiene, produced by Streptomyces sp. I. Taxonomy, production, isolation, physicochemical properties and biological activities. Journal of Antibiotics 55(10): 855-862
Sakai, Y.; Tsujita, T.; Akiyama, T.; Yoshida, T.; Mizukami, T.; Akinaga, S.; Horinouchi, S.; Yoshida, M.; Yoshida, T. 2002: GEX1 compounds, novel antitumor antibiotics related to herboxidiene, produced by Streptomyces sp. II. The effects on cell cycle progression and gene expression. Journal of Antibiotics 55(10): 863-872
Hauss, P.; Mazerolles, F.; Hivroz, C.; Lecomte, O.; Barbat, C.; Fischer, A. 1993: GF109203X, a specific PKC inhibitor, abrogates anti-CD3 antibody-induced upregulation of CD4+ T cell adhesion to B cells. Cellular Immunology 150(2): 439-446
Alegria, A.; Barbera, R.; Farré, R.; Moreno, A. 1994: GFAAS determination of selenium in infant formulas using a microwave digestion method. Die Nahrung 38(4): 382-385
Sirl, W.R. 1980: GFAHA: EMS committee coordinates variety of activities. Michigan hospitals 16(1): 25
Ikeno, Y.; Shimokawa, I.; Higami, Y.; Ikeda, T. 1993: GFAP expression in the subcutaneous tumors of immature glial cell line (HITS glioma) derived from ENU-induced rat glioma. Journal of Neuro-Oncology 17(3): 191-204
Kálmán, M.ál. 2002: GFAP expression withdraws--a trend of glial evolution?. Brain Research Bulletin 57(3-4): 509-511
Krammer, H.J.; Sigge, W. 1994: GFAP immunoreactivity in newly formed ileal mucosa in a serosal patch in dog colon. Annals of Anatomy 176(1): 17-21
Liedtke, W.; Edelmann, W.; Bieri, P.L.; Chiu, F.C.; Cowan, N.J.; Kucherlapati, R.; Raine, C.S. 1996: GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination. Neuron 17(4): 607-615
Menet, V.; Giménez Y Ribotta, M.; Sandillon, F.; Privat, A. 2000: GFAP null astrocytes are a favorable substrate for neuronal survival and neurite growth. Glia 31(3): 267-272
Nolte, C.; Matyash, M.; Pivneva, T.; Schipke, C.G.; Ohlemeyer, C.; Hanisch, U.K.; Kirchhoff, F.; Kettenmann, H. 2001: GFAP promoter-controlled EGFP-expressing transgenic mice: a tool to visualize astrocytes and astrogliosis in living brain tissue. Glia 33(1): 72-86
Martinez, G.; Carnazza, M.L.; Di Giacomo, C.; Sorrenti, V.; Avitabile, M.; Vanella, A. 1998: GFAP, S-100 and vimentin proteins in rat after cerebral post-ischemic reperfusion. International Journal of Developmental Neuroscience: the Official Journal of the International Society for Developmental Neuroscience 16(6): 519-526
Kumar, K.; Wu, X.; Evans, A.T. 1997: GFAP-immunoreactivity following hypothermic forebrain ischemia. Metabolic Brain Disease 12(1): 21-27
Goodwin, P.C. 1999: GFP biofluorescence: imaging gene expression and protein dynamics in living cells. Design considerations for a fluorescence imaging laboratory. Methods in Cell Biology 58: 343-367
Sawin, K.E. 1999: GFP fusion proteins as probes for cytology in fission yeast. Methods in Cell Biology 58: 123-138
Haseloff, J.; Amos, B. 1995: GFP in plants. Trends in Genetics: Tig 11(8): 328-329
Matus, A. 2001: GFP moves on. Trends in Cell Biology 11(5): 183
Arnaud, L.; Pines, J.; Nigg, E.A. 1998: GFP tagging reveals human Polo-like kinase 1 at the kinetochore/centromere region of mitotic chromosomes. Chromosoma 107(6-7): 424-429
Haseloff, J. 1999: GFP variants for multispectral imaging of living cells. Methods in Cell Biology 58: 139-151
White, R.A.; Pan, Z.; Salisbury, J.L. 2000: GFP-centrin as a marker for centriole dynamics in living cells. Microscopy Research and Technique 49(5): 451-457
D'Assoro, A.B.; Stivala, F.; Barrett, S.; Ferrigno, G.; Salisbury, J.L. 2001: GFP-centrin as a marker for centriole dynamics in the human breast cancer cell line MCF-7. Italian Journal of Anatomy and Embryology 106(2 Suppl 1: 103-110
Matsushita, K.; Sugiura, Y. 2003: GFP-linked zinc finger protein sp1. fluorescence study and implication for N-terminal zinc finger 1 as hinge finger. Bioorganic and Medicinal Chemistry 11(1): 53-58
Wu, C.-F.; Cha, H.J.; Valdes, J.J.; Bentley, W.E. 2002: GFP-visualized immobilized enzymes: degradation of paraoxon via organophosphorus hydrolase in a packed column. Biotechnology and Bioengineering 77(2): 212-218
Sarabi, A.; Hoffer, B.J.; Olson, L.; Morales, M. 2000: GFR alpha-1 is expressed in parvalbumin GABAergic neurons in the hippocampus. Brain Research 877(2): 262-270
Enokido, Y.; de Sauvage, F.; Hongo, J.A.; Ninkina, N.; Rosenthal, A.; Buchman, V.L.; Davies, A.M. 1998: GFR alpha-4 and the tyrosine kinase Ret form a functional receptor complex for persephin. Current Biology: Cb 8(18): 1019-1022
Enomoto, H.; Araki, T.; Jackman, A.; Heuckeroth, R.O.; Snider, W.D.; Johnson, E.M.; Milbrandt, J. 1998: GFR alpha1-deficient mice have deficits in the enteric nervous system and kidneys. Neuron 21(2): 317-324
Nishino, J.; Mochida, K.; Ohfuji, Y.; Shimazaki, T.; Meno, C.; Ohishi, S.; Matsuda, Y.; Fujii, H.; Saijoh, Y.; Hamada, H. 1999: GFR alpha3, a component of the artemin receptor, is required for migration and survival of the superior cervical ganglion. Neuron 23(4): 725-736
Wilson, D.M.; Bergert, J.H.; Larson, T.S.; Liedtke, R.R. 1997: GFR determined by nonradiolabeled iothalamate using capillary electrophoresis. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 30(5): 646-652
Phillips, R.; Nicolin, G. 2000: GFR estimation in paediatric oncology. Archives of Disease in Childhood 82(5): 428
Garcès, A.; Haase, G.; Airaksinen, M.S.; Livet, J.; Filippi, P.; deLapeyrière, O. 2000: GFRalpha 1 is required for development of distinct subpopulations of motoneuron. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 20(13): 4992-5000
Jing, S.; Yu, Y.; Fang, M.; Hu, Z.; Holst, P.L.; Boone, T.; Delaney, J.; Schultz, H.; Zhou, R.; Fox, G.M. 1997: GFRalpha-2 and GFRalpha-3 are two new receptors for ligands of the GDNF family. Journal of Biological Chemistry 272(52): 33111-33117
Fein, R.L. 1994: GFS Mark Ii inflatable penile prosthesis: four-year clinical study. Urology 43(2): 209-213
Cooper, R.; Dragar, C.; Elliot, K.; Fitton, J.H.; Godwin, J.; Thompson, K. 2002: GFS, a preparation of Tasmanian Undaria pinnatifida is associated with healing and inhibition of reactivation of Herpes. Bmc Complementary and Alternative Medicine 2: 11
Legendre, F.; Kozelka, J.í; Chottard, J.-C. 1998: GG versus AG Platination: a Kinetic Study on Hairpin-Stabilized Duplex Oligonucleotides. Inorganic Chemistry 37(16): 3964-3967
Sakamoto, N.; Larson, J.E.; Iyer, R.R.; Montermini, L.; Pandolfo, M.; Wells, R.D. 2001: GGA*TCC-interrupted triplets in long GAA*TTC repeats inhibit the formation of triplex and sticky DNA structures, alleviate transcription inhibition, and reduce genetic instabilities. Journal of Biological Chemistry 276(29): 27178-27187
Pei, J.; Grishin, N.V. 2001: GGDEF domain is homologous to adenylyl cyclase. Proteins 42(2): 210-216
Canoll, P.D.; Musacchio, J.M.; Hardy, R.; Reynolds, R.; Marchionni, M.A.; Salzer, J.L. 1996: GGF/neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitors. Neuron 17(2): 229-243
Thybaut, N.; Deleu, S. 2001: GGG around the Netherlands. Discussion with members serves as basis for agenda. Tijdschrift Voor Diergeneeskunde 126(22): 732-733
Avila, M.; Ortiz, G.; Lozano, J.M.; Franco, P.; Patarroyo, M.E. 2001: GGRGDSPCA peptide: a new antiscarring agent on glaucoma filtration surgery. Ophthalmic Surgery and Lasers 32(2): 134-139
Moseley, C.T.; Orenstein, M.D.; Phillips, J.A. 2002: GH Gene Deletions and IGHD type IA. Reviews in Endocrine and Metabolic Disorders 3(4): 339-346
Tanaka, T.; Satoh, M.; Yasunaga, T.; Horikawa, R.; Tanae, A.; Hibi, I. 1997: GH and GnRH analog treatment in children who enter puberty at short stature. Journal of Pediatric Endocrinology and Metabolism: Jpem 10(6): 623-628
Louveau, I.; Quesnel, H.; Prunier, A. 2000: GH and IGF-i binding sites in adipose tissue, liver, skeletal muscle and ovaries of feed-restricted gilts. Reproduction Nutrition Development 40(6): 571-578
Kobayashi, I.; Kameya, T.; Oka, H.; Naritaka, H.; Kawano, N.; Fujii, K. 1999: GH and PRL-Producing Pituitary Adenoma with Neuron-Like Differentiation. Endocrine Pathology 10(4): 367-374
Isaksson, O.G.; Ohlsson, C.; Bengtsson, B.A.; Johannsson, G. 2000: GH and bone--experimental and clinical studies. Endocrine Journal 47 Suppl: S9-16
Zarrilli, L.; Marzano, L.A.; D'Avanzo, A.; Notarangelo, C.; Porcelli, A.; Ciafrone, M. 1993: GH and surgery. Minerva Endocrinologica 18(3 Suppl 1: 76-78
Isgaard, J.; Bengtsson, B.A. 2000: GH and the heart: potential therapeutic use. Growth Hormone and Igf Research: Official Journal of the Growth Hormone Research Society and the International Igf Research Society 10(6): 295-296
Gaia, D.; Gasco, V.; Razzore, P.; Ciccarelli, E.; Camanni, F.; Ghigo, E.; Grottoli, S. 2002: GH but not IGF-i hypersecretion in acromegaly is generally attenuated in elderly acromegalics. Journal of Endocrinological Investigation 25(10 Suppl): 51-52
Merola, B.; Longobardi, S.; Colao, A.; Rossi, E.; Esposito, V.; Lombardi, G. 1993: GH deficiency in the adult. Minerva Endocrinologica 18(3 Suppl 1: 66-68
Dattani, M.T. 2002: GH deficiency might be associated with normal height in PROP1 deficiency. Clinical Endocrinology 57(2): 157-158
De Marinis, L.; Mancini, A.; Giampietro, A.; Gentilella, R.; Bianchi, A.; Perrelli, M.; Vezzosi, C.; Milardi, D.; Fusco, A.; Valle, D.; Bernabei, R. 2002: GH deficiency syndrome in elderly patients. Journal of Endocrinological Investigation 25(10 Suppl): 40-41
Matsuzaki, F. 1997: GH receptor function and its evaluation. Nihon Rinsho. Japanese Journal of Clinical Medicine 55(Suppl 2): 483-486
Kaji, H. 1998: GH receptor gene mutations and growth failure. Nihon Rinsho. Japanese Journal of Clinical Medicine 56(7): 1830-1835
Svensson, J.; Bengtsson, B.A.; Taskinen, M.R.; Wiklund, O.; Johannsson, G. 2000: A nine-month, placebo-controlled study of the effects of growth hormone treatment on lipoproteins and LDL size in abdominally obese men. Growth Hormone and Igf Research: Official Journal of the Growth Hormone Research Society and the International Igf Research Society 10(3): 118-126
Bowers, C.Y. 1993: GH releasing peptides--structure and kinetics. Journal of Pediatric Endocrinology 6(1): 21-31
Fisker, S.; Jørgensen, J.O.; Orskov, H.; Christiansen, J.S. 1998: GH stimulation tests: evaluation of GH responses to heat test versus insulin-tolerance test. European Journal of Endocrinology 139(6): 605-610
Kindblom, J.M.; Göthe, S.; Forrest, D.; Törnell, J.; Törnell, J.; Vennström, B.; Ohlsson, C. 2001: GH substitution reverses the growth phenotype but not the defective ossification in thyroid hormone receptor alpha 1-/-beta-/- mice. Journal of Endocrinology 171(1): 15-22
Pfaffle, R.W.; Kim, C.; Blankenstein, O.; Kentrup, H. 1999: GH transcription factors. Journal of Pediatric Endocrinology and Metabolism: Jpem 12 Suppl. 1: 311-317
Münscher, A.; Schmid, M.; Saeger, W.; Schreiber, S.; Lüdecke, D.K. 2001: GH-, PRL-, POMC-, beta-TSH-, beta-LH-, beta-FSH-mRNA in gonadotroph adenomas of the pituitary by in situ hybridization in comparison with immunostaining and clinical data. Endocrine Pathology 12(2): 171-180
Imazio, M.; Bobbio, M.; Broglio, F.; Benso, A.; Podio, V.; Valetto, M.R.; Bisi, G.; Ghigo, E.; Trevi, G.P. 2002: GH-independent cardiotropic activities of hexarelin in patients with severe left ventricular dysfunction due to dilated and ischemic cardiomyopathy. European Journal of Heart Failure 4(2): 185-191
Corrias, A.; Bellone, J.; Beccaria, L.; Bosio, L.; Trifirò, G.; Livieri, C.; Ragusa, L.; Salvatoni, A.; Andreo, M.; Ciampalini, P.; Tonini, G.; Crinò, A. 2000: GH/IGF-I axis in Prader-Willi syndrome: evaluation of IGF-I levels and of the somatotroph responsiveness to various provocative stimuli. Genetic Obesity Study Group of Italian Society of Pediatric Endocrinology and Diabetology. Journal of endocrinological investigation 23(2): 84-89
Ham, J.; Ivan, M.; Wynford-Thomas, D.; Scanlon, M.F. 1997: GH3 cells expressing constitutively active Gs alpha (Q227L) show enhanced hormone secretion and proliferation. Molecular and Cellular Endocrinology 127(1): 41-47
Anonymous 2002: GHA President Joseph Parker wins prestigious AHA Trustees Award. Gha Today 46(4): 1 7
Caesar, N. 1995: New Stark regs threaten groups' ties to independent physicians. Managed Care 4(12): 14-15
Anonymous 1996: GHA partnerships take aim at healthy communities. Georgia Hospitals Today 40(6): 1 6
Wolf, M.A.; Yassa, R.; Llorca, P.M. 2002: Neuroleptic-induced movement disorders: historical perspectives. L'Encephale 19(6): 657-661
Anonymous 1998: GHA'S TELNET expands to other states; South Carolina and Virginia first to sign on. GHA today 42(1): 5
Anonymous 1998: GHA's data services team. Gha Today 42(4): 6
Gallino, A.; Moccetti, T.; Hirzel, H.; Meier, B. 2018: A Man With a 40-Year Event-Free Follow-Up After Percutaneous Coronary Intervention. Jacc. Cardiovascular Interventions 11(9): 911
Anonymous 1998: GHA, AHA join forces on health care compliance. Gha Today 42(11): 1 8
Parker, J.A. 1997: Nation awakens to the plight of rural hospitals. Gha Today 41(10): 7
Conklin, M. 1994: Sutter begins all-or-nothing contracting. Health Care Strategic Management 12(10): 12-13
Weissenstein, E. 1995: GHAA forms own physician group. Modern Healthcare 25(30): 8
Weissenstein, E. 1995: GHAA wants more choice for Medicare. Modern Healthcare 25(27): 8
Kertesz, L. 1995: GHAA-AMCRA merger in the offing. Modern Healthcare 25(33): 16
Robinson, M.L. 1987: GHAA: an association in transition. Making and shaping health policy--Part V. Internist 28(5): 18-20
Mills, R.; Galdabini, G. 1999: Managed care tools becoming a chief U.S. export. Executive Solutions for Healthcare Management 2(1): 1; 4-7
Muller, A.A. 2003: GHB poisoning: three recent cases reflect the continuing danger. Journal of Emergency Nursing 29(1): 72-74
Persson, S.A.; Eriksson, A.; Hallgren, N.; Eklund, A.; Berkowicz, A.; Druid, H. 2001: GHB--dangerous, addictive and uncontrollable "party drug". Lakartidningen 98(38): 4026
Nicholson, K.L.; Balster, R.L. 2001: GHB: a new and novel drug of abuse. Drug and Alcohol Dependence 63(1): 1-22
Okun, M.S.; Boothby, L.A.; Bartfield, R.B.; Doering, P.L. 2001: GHB: an important pharmacologic and clinical update. Journal of Pharmacy and Pharmaceutical Sciences: a Publication of the Canadian Society for Pharmaceutical Sciences Societe Canadienne des Sciences Pharmaceutiques 4(2): 167-175
Anonymous 2001: GHB: its use and misuse. Harvard Mental Health Letter 17(9): 7-8
Flamm, C.R.; Aronson, N.; Bohn, R.; Finkelstein, B.; Piper, M.; Seidenfeld, J.; Bonnell, C.J.; Carter, M.; Gere, M.; Ziegler, K.M. 2001: Use of epoetin for anemia in chronic renal failure. Evidence Report/Technology Assessment 5(29): 1-8
Nudelman, P.M.; Madsen, S.A. 1982: GHC's innovative pharmacy system. Hospital Materiel Management Quarterly 4(1): 1-10
Baumann, G. 2002: GHRH receptor defects. Journal of Pediatric Endocrinology and Metabolism: Jpem 15 Suppl. 5: 1431-1433
Hewson, A.K.; Viltart, O.; McKenzie, D.N.; Dyball, R.E.; Dickson, S.L. 1999: GHRP-6-induced changes in electrical activity of single cells in the arcuate, ventromedial and periventricular nucleus neurones [correction of nuclei] of a hypothalamic slice preparation in vitro. Journal of Neuroendocrinology 11(12): 919-923
Anonymous 1995: GHS (Graduate Health System) links regional network of care. Health management technology 16(1): 20
DeJohn, P. 2003: GHX and Medibuy merge, create e-commerce giant. Hospital Material Dollar Sign Management 28(1): 1; 9-1,10
Shehata, A. 2002: Strengthening system security to prepare for HIPAA. Health Management Technology 23(9): 14-15; 19
Papoz, L.; Favier, F.; Clabé, A.; Sanchez, A.; Le Moullec, N. 2000: GHb (HbA(1c)) is more sensitive than fasting blood glucose as a screening test for diabetes. Diabetes Care 23(8): 1206-7; author reply 1208
Park, S.; Barrett-Connor, E.; Wingard, D.L.; Shan, J.; Edelstein, S. 1996: GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes. the Rancho Bernardo Study. Diabetes Care 19(5): 450-456
Koivisto, V. 1995: GHbA1c and peoples democracy. Duodecim; Laaketieteellinen Aikakauskirja 111(24): 2430
Mathias, J.M. 2002: Review these common documentation errors. Or Manager 18(10): 40-42
Mansour-Ghanaei, F.; Zareh, S.; Salimi, A. 2002: GI anthrax: report of one case confirmed with autopsy. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 8(9): Cs73-Cs76
Lane, J.E.; Ajjan, M.; Sedghi, S. 2001: Gi bleeding from duodenal diverticula. American Journal of Gastroenterology 96(9): 2799-2800
Narayani, R.I.; Brady, C. 2002: Gi bleeding from ileocecal Mycobacterium tuberculosis. Gastrointestinal Endoscopy 55(1): 83
Galasso, P.J.; Keung, Y.K. 1997: Gi cancer and iron deficiency anemia. Journal of Family Practice 45(6): 464
Rosenberg, C.A. 1996: GI cocktail. Annals of Emergency Medicine 28(1): 104-105
Gilljam, M.; Chaparro, C.; Tullis, E.; Chan, C.; Keshavjee, S.; Hutcheon, M. 2003: Gi complications after lung transplantation in patients with cystic fibrosis. Chest 123(1): 37-41
Everette, S.S. 1995: Gi distress: clues in the patient's medications. Gastroenterology Nursing: the Official Journal of the Society of Gastroenterology Nurses and Associates 18(6): 219-223
Garnett, W.R. 1996: GI effects of OTC analgesics: implications for product selection. Journal of the American Pharmaceutical Association Ns36(9): 565-572
Swaim, M.W.; Wilson, J.A. 1999: Gi emergencies: rapid therapeutic responses for older patients. Geriatrics 54(6): 20
Cheung, R.J.; Ortiz, D.; DiMarino, A.J. 1999: Gi endoscopic reprocessing practices in the United States. Gastrointestinal Endoscopy 50(3): 362-368
DiMarino, A.J. 1999: Gi endoscopic reprocessing: maintaining public confidence in the face of decreasing reimbursements. Gastrointestinal Endoscopy 50(4): 585-588
Zhang, Q.-L.; Yu, Z.-L. 2002: Gi endoscopy in China. Gastrointestinal Endoscopy 55(7): 963-964
Soweid, A.; Shammaa, M.; Khouri, K. 2001: Gi endoscopy in Lebanon: past, present, and future. Gastrointestinal Endoscopy 54(2): 279-281
Renkes, J. 1993: Gi endoscopy--managing the full scope of care. Nursing 23(6): 50-55
Weaver, J.; Bonnel, R.A.; Karwoski, C.B.; Brinker, A.D.; Beitz, J. 2001: GI events leading to death in association with celecoxib and rofecoxib. American Journal of Gastroenterology 96(12): 3449-3450
Poon, R.T.; Tuen, H.; Yeung, C. 2000: Gi hemorrhage from fistula between right hepatic artery pseudoaneurysm and the duodenum secondary to acute cholecystitis. Gastrointestinal Endoscopy 51(4 Part 1): 491-493
Esaki, M.; Matsumoto, T.; Nakamura, S.; Kawasaki, M.; Iwai, K.; Hirakawa, K.; Tarumi, K.-I.; Yao, T.; Iida, M. 2002: Gi involvement in Henoch-Schönlein purpura. Gastrointestinal Endoscopy 56(6): 920-923
Dill, B.P. 2002: Gi journeys across the U.S. Gastroenterology Nursing: the Official Journal of the Society of Gastroenterology Nurses and Associates 25(4): 167-169
Poré, G. 2002: Gi lesions in Henoch-Schönlein purpura. Gastrointestinal Endoscopy 55(2): 283-286
Anderson, C.M. 2002: Gi magnetic resonance angiography. Gastrointestinal Endoscopy 55(7 Suppl): S42-S48
Dupont, C. 2001: Gi manifestations of food allergy. Pediatric Allergy and Immunology: Official Publication of the European Society of Pediatric Allergy and Immunology 12(Suppl 14): 41-42
Räihä, I.; Sourander, L. 1993: Gi motility disorders: diagnostic workup and use of prokinetic therapy. Geriatrics 48(11): 57-60; 65-66
Stone, J.; Schluterman, S.; Perry, L.; Galyen, L.; Drews, B. 1996: GI nurses' retrospective look at foreign body ingestions in children. Gastroenterology Nursing: the Official Journal of the Society of Gastroenterology Nurses and Associates 19(2): 70-71
Huber, D.; Hemstrom, M. 1994: Gi nursing: the community health aspect. Gastroenterology Nursing: the Official Journal of the Society of Gastroenterology Nurses and Associates 16(5): 219-223
Cohen, L.B. 2000: Gi sources on the internet. American Journal of Gastroenterology 95(3): 820
Wang, G.; McFarland, E.G.; Brown, B.P.; Vannier, M.W. 1998: GI tract unraveling with curved cross sections. IEEE Transactions on Medical Imaging 17(2): 318-322
Keystone, J.S. 1999: GIDEON computer program for diagnosing and teaching geographic medicine. Journal of Travel Medicine 6(2): 152-154
Lesser, M.F. 1994: GIFIC. a graphical interface for intensive care. PROCEEDINGS. Symposium on Computer Applications in Medical Care 1994: 988
Cataldo, P.J. 1997: GIFT as assistance. Ethics and Medics 22(12): 3-4
Abyholm, T.; Tanbo, T. 1993: GIFT, ZIFT, and related techniques. Current Opinion in Obstetrics and Gynecology 5(5): 615-622
Haas, J.M. 1993: GIFT? No!. Ethics and Medics 18(9): 1-3
McCarthy, D. 1993: GIFT? Yes!. Ethics and Medics 18(9): 3-4
Sothern, R.B.; Tseng, T.-S.; Orcutt, S.L.; Olszewski, N.E.; Koukkari, W.L. 2002: GIGANTEA and SPINDLY genes linked to the clock pathway that controls circadian characteristics of transpiration in Arabidopsis. Chronobiology International 19(6): 1005-1022
Riccardi, C.; Bruscoli, S.; Ayroldi, E.; Agostini, M.; Migliorati, G. 2001: GILZ, a glucocorticoid hormone induced gene, modulates T lymphocytes activation and death through interaction with NF-kB. Advances in Experimental Medicine and Biology 495: 31-39
Fleetcroft, R. 1999: GIM and specialty medicine. Journal of the Royal College of Physicians of London 33(5): 486-487
Özer 1996: GIM mechanism and its consequences in the SU(3)L x U(1)X models of electroweak interactions. Physical Review. D Particles and Fields 54(7): 4561-4565
Buchalla; Burdman; Hill; Kominis 1996: GIM violation and new dynamics of the third generation. Physical Review. D Particles and Fields 53(9): 5185-5200
Göbel, G.; Pfeiffer, K.P. 1999: GIN AUSTRIA. Assuring quality and relevance on Internet-health-informations for patients. Studies in Health Technology and Informatics 68: 562-567
Haag-Weber, M.; Mai, B.; Cohen, G.; Hörl, W.H. 1994: GIP and DIP: a new view of uraemic toxicity. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 9(4): 346-347
Furbee, P.M. 1995: GIS (geographic information systems) in Raleigh County. Small towns with a big database. Jems: a Journal of Emergency Medical Services 20(6): 77 79 81
Hanchette, C.L. 1999: GIS and decision making for public health agencies: childhood lead poisoning and welfare reform. Journal of Public Health Management and Practice: Jphmp 5(4): 41-47
Roper, W.L.; Mays, G.P. 1999: GIS and public health policy: a new frontier for improving community health. Journal of Public Health Management and Practice: Jphmp 5(2): Vi-Vii
Villalon, M. 1999: GIS and the Internet: tools that add value to your health plan. Health Management Technology 20(9): 16-18
Van der Wel, T.; van Dijk, L.J.D.; de Vries, A.C. 2018: A man with abdominal bloating. Nederlands Tijdschrift Voor Geneeskunde 162
Lubenow, A.; Tolson, K. 2001: GIS technology helps pinpoint patients. Health Management Technology 22(1): 54-55
Brunn, S.D.; Dahlman, C.T.; Taylor, J.S. 1998: GIS uses and constraints on diffusion in Eastern European and the former USSR. Post-Soviet Geography and Economics 39(10): 566-587
Sui, D.Z. 1998: GIS-based urban modelling: practices, problems, and prospects. International Journal of Geographical Information Science: Ijgis 12(7): 651-671
Wilkinson, D.; Tanser, F. 1999: GIS/GPS to document increased access to community-based treatment for tuberculosis in Africa. Geographic information system/global positioning system. Lancet 354(9176): 394-395
Schriner, M.W. 1998: GIS: mapping the gap between providers and members. Infocare: Information Strategies for Healthcare Networks 1998: 26-29
Davenhall, B. 1999: GIS: putting data into motion. Health Management Technology 20(9): 64; 63
Pioltelli, P.; Maldifassi, P.; Vacca, A.; Mazzaro, C.; Mussini, C.; Migliaresi, S.; Gabrielli, A.; Pietrogrande, M.; Monteverde, A.; Monti, G. 1995: GISC protocol experience in the treatment of essential mixed cryoglobulinaemia. Clinical and Experimental Rheumatology 13(Suppl 13): S187-S190
Heinzl, S. 1994: GISSI-3 and ISIS-4: administration of ACE inhibitors soon after myocardial infarct. Medizinische Monatsschrift für Pharmazeuten 17(1): 1
Anonymous 1994: GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico. Lancet 343(8906): 1115-1122
Harrison, R.; Burr, M.; Elton, P. 1999: GISSI-Prevenzione trial. Lancet 354(9189): 1554-5; Author Reply 1556-7
Salen, P.; de Lorgeril, M. 1999: GISSI-Prevenzione trial. Lancet 354(9189): 1555; Author Reply 1556-7
Rhatigan, R.M. 2002: GIST nomenclature. Human Pathology 33(12): 1242
Roberts, P.J. 1998: GIST. Gastrointestinal stromal tumours. Annales Chirurgiae et Gynaecologiae 87(4): 277
Halushka, M.K.; Mathews, D.J.; Bailey, J.A.; Chakravarti, A. 1999: GIST: a web tool for collecting gene information. Physiological Genomics 1(2): 75-81
Vitale, N.; Patton, W.A.; Moss, J.; Vaughan, M.; Lefkowitz, R.J.; Premont, R.T. 2000: GIT proteins, a novel family of phosphatidylinositol 3,4, 5-trisphosphate-stimulated GTPase-activating proteins for ARF6. Journal of Biological Chemistry 275(18): 13901-13906
Kudo, T.; Ikeda, K.; Oshima, T.; Kure, S.; Tammasaeng, M.; Prasansuk, S.; Matsubara, Y. 2001: GJB2 (connexin 26) mutations and childhood deafness in Thailand. Otology and Neurotology: Official Publication of the American Otological Society American Neurotology Society and European Academy of Otology and Neurotology 22(6): 858-861
Angeli, S.; Utrera, R.; Dib, S.; Chiossone, E.; Naranjo, C.; Henríquez, O.; Porta, M. 2000: GJB2 gene mutations in childhood deafness. Acta Oto-Laryngologica 120(2): 133-136
Najmabadi, H.; Cucci, R.A.; Sahebjam, S.; Kouchakian, N.; Farhadi, M.; Kahrizi, K.; Arzhangi, S.; Daneshmandan, N.; Javan, K.; Smith, R.J.H. 2002: GJB2 mutations in Iranians with autosomal recessive non-syndromic sensorineural hearing loss. Human Mutation 19(5): 572
Suzuki, S.; Toyota, T. 1998: GK rat. Nihon Rinsho. Japanese Journal of Clinical Medicine 56 Suppl. 3: 695-699
Yamada, M.; Jahangir, A.; Hosoya, Y.; Inanobe, A.; Katada, T.; Kurachi, Y. 1993: GK* and brain G beta gamma activate muscarinic K+ channel through the same mechanism. Journal of Biological Chemistry 268(33): 24551-24554
Fritze, J.; Sass, H.; Möller, H.J. 1999: GKV Health Reform 2000--cabinet proposal for the regulation. Combined position of the German Society of Psychiatry, Psychotherapy and Neurology and the Study Group for Neuropsychopharmacology and Pharmacopsychiatry. Der Nervenarzt 70(8): 766-771
Jentsch, P. 2001: GKV reform: the parties question the medical care catalog. Advantage for physicians: new reimbursement alternatives. MMW Fortschritte der Medizin 143(42): 54-55
Kim; Soh; Yee 1993: GL(2,R) gauge theory of (1+1)-dimensional gravity. Physical Review. D Particles and Fields 47(10): 4433-4437
Norman, P. 2001: GL-701 Genelabs. Current Opinion in Investigational Drugs 2(2): 231-236
Masago, A.; Shimada, S.; Minami, Y.; Inoue, K.; Morimura, H.; Otori, Y.; Miyai, A.; Tohyama, M.; Yamada, K. 1996: GLAST mRNA expression in the periventricular area of experimental hydrocephalus. Neuroreport 7(15-17): 2565-2570
Itz, C.A. 2000: GLBT campuslife on the Web. Journal of Homosexuality 40(1): 189-191
Kaushik, N.; Agnihotri, A. 2000: GLC analysis of Indian rapeseed-mustard to study the variability of fatty acid composition. Biochemical Society Transactions 28(6): 581-583
Bjellerup, P.; Kallner, A.; Kollind, M. 1994: GLC determination of serum-ethylene glycol, interferences in ketotic patients. Journal of Toxicology. Clinical Toxicology 32(1): 85-87
Wang, D.; Shortliffe, E.H. 2002: GLEE--a model-driven execution system for computer-based implementation of clinical practice guidelines. Proceedings. AMIA Symposium 2002: 855-859
Myklebost, O. 1998: GLI gene and rhabdomyosarcoma. Nature Medicine 4(8): 869
Peleg, M.; Boxwala, A.A.; Ogunyemi, O.; Zeng, Q.; Tu, S.; Lacson, R.; Bernstam, E.; Ash, N.; Mork, P.; Ohno-Machado, L.; Shortliffe, E.H.; Greenes, R.A. 2000: GLIF3: the evolution of a guideline representation format. Proceedings. AMIA Symposium 2000: 645-649
Feng, D.; Ho, D.; Lau, K.K.; Siu, W.C. 1999: GLLS for optimally sampled continuous dynamic system modeling: theory and algorithm. Computer Methods and Programs in Biomedicine 59(1): 31-43
Souquet, P.J.; Tan, E.H.; Rodrigues Pereira, J.; Van Klaveren, R.; Price, A.; Gatzemeier, U.; Jaworski, M.; Burillon, J.P.; Aubert, D. 2002: GLOB-1: a prospective randomised clinical phase IIi trial comparing vinorelbine-cisplatin with vinorelbine-ifosfamide-cisplatin in metastatic non-small-cell lung cancer patients. Annals of Oncology: Official Journal of the European Society for Medical Oncology 13(12): 1853-1861
Toledo Pallarés, J. 2001: GLOBAlink: an international network for the prevention and control of smoking. Gaceta Sanitaria 15(1): 74-75
Tapia Granados, J.A.; Diez Roux, A.V.; Nieto, F.J. 1994: GLOEPI. English-Spanish glossary of epidemiology and health statistics terms. Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau 117(3): 239-257
Isaman, V. 1997: GLP soil characterization--the laboratory. Quality Assurance 5(1): 49-53
Gutniak, M. 1998: GLP-1 (7-36) amide [GLIP-glucagon like insulinotropic peptide] as a potential treatment for NIDDM. Journees Annuelles de Diabetologie de l'Hotel-Dieu 1998: 157-171
Suga, S.; Kanno, T.; Dobashi, Y.; Wakui, M. 1997: GLP-1 (7-36) amide activates L-type Ca2+ channels of pancreatic B-cells through c-AMP signaling. Japanese Journal of Physiology 47(Suppl 1): S13-S14
Matsuyama, T.; Komatsu, R. 1999: GLP-1 (glucagon-like peptide 1). Nihon Rinsho. Japanese Journal of Clinical Medicine 57 Suppl: 323-325
Thorens, B. 1994: GLP-1 and the control of insulin secretion. Journees Annuelles de Diabetologie de l'Hotel-Dieu 1994: 33-46
Thompson, D.G. 2000: GLP-1 and the gut. Gut 46(5): 591
Márquez, L.; González, N.; Puente, J.; Valverde, L.; Villanueva-Peñacarrillo, M.L. 2001: GLP-1 effect upon the GPI/IPG system in adipocytes and hepatocytes from diabetic rats. Diabetes Nutrition and Metabolism 14(5): 239-244
Holst, J.J. 1996: GLP-1 in NIDDM. Diabetic Medicine: a Journal of the British Diabetic Association 13(9 Suppl 6: S156-S160
Gallwitz, B.; Schmidt, W.E. 1997: GLP-1 receptor gen "knock out" causes glucose intolerance, but no alterations of eating behavior. Zeitschrift für Gastroenterologie 35(8): 655-658
Rosselin, G.; Leclercq-Meyer, V.; Boissart, C.; Pessah, M.; Malaisse, W.J. 1998: GLP-1 receptors in golden Syrian hamster islets: identification and functional characterization. Endocrine 8(3): 323-330
Gutniak, M.K.; Larsson, H.; Sanders, S.W.; Juneskans, O.; Holst, J.J.; Ahrén, B. 1997: GLP-1 tablet in type 2 diabetes in fasting and postprandial conditions. Diabetes Care 20(12): 1874-1879
Buchman, A.L. 2001: GLP-2 and nutrient absorption. Current Gastroenterology Reports 3(4): 331
Warner, B.W. 2001: GLP-2 as therapy for the short-bowel syndrome. Gastroenterology 120(4): 1041-1043
Gordon, D. 1999: GLP-2 cloning may lead to therapy for intestinal deficiency diseases. Gastroenterology 116(4): 786
Prasad, R.; Alavi, K.; Schwartz, M.Z. 2001: GLP-2alpha accelerates recovery of mucosal absorptive function after intestinal ischemia/reperfusion. Journal of Pediatric Surgery 36(4): 570-572
Perkin, C.J. 1995: GLP: testing facility management responsibilities--contract research organization perspective. Quality Assurance 4(4): 297-307
Borghouts, L.B.; Schaart, G.; Hesselink, M.K.; Keizer, H.A. 2000: GLUT-4 expression is not consistently higher in type-1 than in type-2 fibres of rat and human vastus lateralis muscles; an immunohistochemical study. Pflugers Archiv: European Journal of Physiology 441(2-3): 351-358
Das, U.N. 1999: GLUT-4, tumour necrosis factor, essential fatty acids and daf-genes and their role in glucose homeostasis, insulin resistance, non-insulin dependent diabetes mellitus, and longevity. Journal of the Association of Physicians of India 47(4): 431-435
Haber, R.S.; Weiser, K.R.; Pritsker, A.; Reder, I.; Burstein, D.E. 1997: GLUT1 glucose transporter expression in benign and malignant thyroid nodules. Thyroid: Official Journal of the American Thyroid Association 7(3): 363-367
Matosin, M.; Allison, G.G.; Ilundain, A.A.; Shirazi-Beechey, S.P.; Brot-Laroche, E. 1996: GLUT1 to 5 & SGLT1 expression in thyroid-hormone-treated Caco-2 cells. Biochemical Society Transactions 24(2): 238S
Thorens, B. 2001: GLUT2 in pancreatic and extra-pancreatic gluco-detection (review). Molecular Membrane Biology 18(4): 265-273
Thorens, B.; Gérard, N.; Dériaz, N. 1993: GLUT2 surface expression and intracellular transport via the constitutive pathway in pancreatic beta cells and insulinoma: evidence for a block in trans-Golgi network exit by brefeldin a. Journal of Cell Biology 123(6 Part 2): 1687-1694
Gaster, M.; Vach, W.; Beck-Nielsen, H.; Schrøder, H.D. 2002: GLUT4 expression at the plasma membrane is related to fibre volume in human skeletal muscle fibres. Apmis: Acta Pathologica Microbiologica et Immunologica Scandinavica 110(9): 611-619
Ralston, E.; Ploug, T. 1996: GLUT4 in cultured skeletal myotubes is segregated from the transferrin receptor and stored in vesicles associated with TGN. Journal of Cell Science 109: 2967-2978
Oatey, P.B.; Van Weering, D.H.; Dobson, S.P.; Gould, G.W.; Tavaré, J.M. 1997: GLUT4 vesicle dynamics in living 3T3 L1 adipocytes visualized with green-fluorescent protein. Biochemical Journal 327: 637-642
Simpson, F.; Whitehead, J.P.; James, D.E. 2001: GLUT4--at the cross roads between membrane trafficking and signal transduction. Traffic 2(1): 2-11
Hundal, H.S.; Darakhshan, F.; Kristiansen, S.; Blakemore, S.J.; Richter, E.A. 1998: GLUT5 expression and fructose transport in human skeletal muscle. Advances in Experimental Medicine and Biology 441: 35-45
Fischer, L.; Kalinina, T.; Rogiers, X.; Will, H.; Sterneck, M. 2001: GLY145ARG mutation emerging under HBIG treatment in patients with recurrent HBV after liver transplantation strongly reduces viral secretion. Transplantation Proceedings 33(7-8): 3633-3636
Oosterwijk, A.J.M.; van den Berg, J.W.; van Rossem, C.C. 2018: A man with abdominal pain, diarrhoea and rectal bleeding. Nederlands Tijdschrift Voor Geneeskunde 162: D2050
Boersen, G.J.; Geijteman, E.C.T.; Schweitzer, D.H. 2018: A man with a black oesophagus. Nederlands Tijdschrift Voor Geneeskunde 162: D1817
Paquot, N.; Scheen, A.J.; Lefèbvre, P.J. 2000: GLycemic control in the diabetic patient. Recommendations after the DCCT and UKPdi studies. Revue Medicale de Liege 55(5): 372-375
Seiser, A.; Pötzl, G.; Safoschnik, G.; Pichler, S.; Bernheimer, H.; Schwerer, B. 1994: GM 1 antibodies in Guillain-Barré syndrome: isotypes, course and clinical outcome. Wiener Klinische Wochenschrift 106(6): 159-163
Pandey, J.P.; Gunsolley, J.C.; Tew, J.G.; Schenkein, H.A. 1996: GM allotypes and IgG subclass concentrations in blacks. Experimental and Clinical Immunogenetics 13(3-4): 126-130
Cubbin, J.; Shaw, D. 2001: GM and DM--a winning team. Health Management Technology 22(4): 28-31
Walter, H.; Matsumoto, H.; Danker-Hopfe, H.; Malhotra, K.C.; Mukherjee, B.N. 1997: GM and KM allotypes in eight tribal populations of Madyha Pradesh and Orissa, India. Japanese Journal of Human Genetics 42(1): 193-203
Coste, C. 1978: GM and health spending: putting the brakes on rising costs. New Physician 27(2): 20-24
Bonetta, L. 2001: GM crops under new US scrutiny. Current Biology: Cb 11(6): R201
Lawson, M.L.; Sochett, E.B.; Frank, M.R.; Fry, M.K.; Stephens, D.; Chait, P.; Daneman, D. 2000: Intensive diabetes management decreases Na-Li countertransport in young subjects with type 1 diabetes and enlarged kidneys. Journal of Diabetes and its Complications 14(6): 333-339
Vickery 2001: GM crops: bad or benign for biodiversity?. Trends in Ecology and Evolution 16(1): 17
Berg, G.H.; Bicknell, W.J. 1977: Project planning without tears. Trustee: the Journal for Hospital Governing Boards 30(2): 14-16
Kilpatrick, D.C. 1999: GM food debate. Lancet 354(9191): 1728; author reply 1728-9
Leckie, J. 2000: GM food: boon or bane?. Nutrition and Health 14(4): 281-284
Dixon, B. 2000: GM frenzy: a lesson in communication. Biologist 47(2): 74-76
Anonymous 2000: GM health food. Nature Biotechnology 18(3): 247
Anonymous 1997: GM helps Ohio hospital redesign care delivery. Patient-focused care: the health care executive's guide to organizational restructuring 5(5): 52-53
Comper, A. 1978: GM looks at the healthcare industry. Surgical Business 41(7): 30-34
Holmes, E. 1978: GM not giving up medical files. Computerworld 12(33): 2+
Miller, H.I. 2002: GM or non-GM?. Trends in Biotechnology 20(1): 8
De Vries GE 2000: GM plants communicate with bacteria. Trends in Plant Science 5(1): 8
Lowes, R.L. 1997: GM wants to tune up your practice. Medical Economics 74(18): 193-194; 201-203
Maes, J. 1979: GM's tough proposal to UAW asks health benefits freeze. Business Insurance 13(18): 10
Koelfen, W.; Freund, M.; Jaschke, W.; Koenig, S.; Schultze, C. 1994: GM-2 gangliosidosis (Sandhoff's disease): two year follow-up by MRi. Neuroradiology 36(2): 152-154
Peeters, T.L. 2001: GM-611 (Chugai Pharmaceutical). Current Opinion in Investigational Drugs 2(4): 555-557
Bianchi, M.; Clavenna, A.; Bondiolotti, G.P.; Ferrario, P.; Panerai, A.E. 1997: GM-CSF affects hypothalamic neurotransmitter levels in mice: involvement of interleukin-1. Neuroreport 8(16): 3587-3590
Bewig, B.; Wang, X.D.; Kirsten, D.; Dalhoff, K.; Schäfer, H. 2000: GM-CSF and GM-CSF beta c receptor in adult patients with pulmonary alveolar proteinosis. European Respiratory Journal 15(2): 350-357
Si, Q.; Cosenza, M.; Zhao, M.-L.; Goldstein, H.; Lee, S.C. 2002: GM-CSF and M-CSF modulate beta-chemokine and HIV-1 expression in microglia. Glia 39(2): 174-183
Aglietta, M. 1994: GM-CSF and dose escalation of chemotherapy. Annals of Oncology: Official Journal of the European Society for Medical Oncology 5(7): 663
Williams, M.A.; Kelsey, S.M.; Newland, A.C. 1999: GM-CSF and stimulation of monocyte/macrophage function in vivo relevance and in vitro observations. European Journal of Cancer 35(Suppl 3): S18-S22
Wheeler, G.; Brodie, G.N. 1998: GM-CSF and wound healing. Medical Journal of Australia 168(11): 580
Elsässer, D.; Stadick, H.; van de Winkel, J.G.; Valerius, T. 1999: GM-CSF as adjuvant for immunotherapy with bispecific antibodies. European Journal of Cancer 35(Suppl 3): S25-S28
Groenewegen, G.; de Gast, G.C. 1999: GM-CSF can cause T cell activation; results of sequential chemo-immunotherapy. European Journal of Cancer 35(Suppl 3): S23-S24
Bretscher, V.; Andreutti, D.; Neuville, P.; Martin, M.; Martin, F.; Lefebvre, O.; Gilles, C.; Benzonana, G.; Gabbiani, G. 2000: GM-CSF expression by tumor cells correlates with aggressivity and with stroma reaction formation. Journal of Submicroscopic Cytology and Pathology 32(4): 525-533
Kelsey, S.M.; Hazel, D.; Murrell, C.; Newland, A.C. 1996: GM-CSF for peripheral blood stem cell harvest in myeloma. British Journal of Haematology 92(2): 505
Ogawa, T.; Kusumoto, M.; Mizumoto, K.; Sato, N.; Nagai, E.; Ikubo, A.; Aoki, Y.; Tanaka, M. 2000: GM-CSF gene therapy using adenoviral vector in hamster pancreatic cancer. Journal of Hepato-Biliary-Pancreatic Surgery 7(3): 306-311
Arnberg, H.; Letocha, H.; Nõu, F.; Westlin, J.F.; Nilsson, S. 1998: GM-CSF in chemotherapy-induced febrile neutropenia--a double-blind randomized study. Anticancer Research 18(2b): 1255-1260
Croockewit, S. 1999: GM-CSF in haematopoietic stem cell transplantation. European Journal of Cancer 35(Suppl 3): S11-S13
Haider, M.Z.; Raghupathy, R.; Azizieh, F.; Abdelsalam, R.; D'Souza, T.M.; Adekile, A.D. 2000: GM-CSF in sickle cell anemia patients with elevated Hb F. Acta Haematologica 102(3): 140-143
Jabłońska, E.; Piecuch, J.; Piotrowski, L.; Grabowska, Z. 2001: GM-CSF in the culture supernatants of neutrophils and serum levels in patients with inflammation and squamous cell carcinoma of oral cavity. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 11(65): 394-397
Wandl, U.B. 1997: GM-CSF in the treatment of skin ulceration in breast cancer. Journal of Wound Care 6(4): 165-166
Flaherty, D.M.; Monick, M.M.; Carter, A.B.; Peterson, M.W.; Hunninghake, G.W. 2001: GM-CSF increases AP-1 DNA binding and Ref-1 amounts in human alveolar macrophages. American Journal of Respiratory Cell and Molecular Biology 25(2): 254-259
Lafeuillade, A.; Poggi, C.; Tamalet, C. 1996: GM-CSF increases HIV-1 load. Lancet 347(9008): 1123-1124
Chen, G.; Grotendorst, G.; Eichholtz, T.; Khalil, N. 2003: GM-CSF increases airway smooth muscle cell connective tissue expression by inducing TGF-beta receptors. American Journal of Physiology. Lung Cellular and Molecular Physiology 284(3): L548-L556
Jaeger, K.; Scheinichen, D.; Heine, J.; Ruschulte, H.; Kuse, E.; Winkler, M.; Leuwer, M. 1999: GM-CSF increases in vitro the respiratory burst of human neutrophils after liver transplantation. Intensive Care Medicine 25(6): 612-615
Levitt, A.; Bello, J.; Shifteh, K. 2018: A man with a Midline Lesion Within the Oral Tongue. JAMA Otolaryngology-- Head and Neck Surgery 144(7): 639-640
Avilés, A.; Nambo, M.J.; Talavera, A.; Rosas, A.; García, E.L.; Díaz-Maqueo, J.C. 1995: GM-CSF instead of hematological support during high-dose chemotherapy for refractory malignant lymphoma. Leukemia and Lymphoma 17(3-4): 327-330
Lee, S.C.; Liu, W.; Brosnan, C.F.; Dickson, D.W. 1994: GM-CSF promotes proliferation of human fetal and adult microglia in primary cultures. Glia 12(4): 309-318
Itälä, M.; Pelliniemi, T.T.; Remes, K. 1996: GM-CSF raises serum levels of beta 2-microglobulin and thymidine kinase in patients with chronic lymphocytic leukaemia. British Journal of Haematology 94(1): 129-132
Esnault, S.ép.; Malter, J.S. 2002: GM-CSF regulation in eosinophils. Archivum Immunologiae et Therapiae Experimentalis 50(2): 121-130
Wilk, J.N.; Viney, J.L. 2002: GM-CSF treatment for Crohn's disease: a stimulating new therapy?. Current Opinion in Investigational Drugs 3(9): 1291-1296
De Nully Brown, P.; Hansen, M.M. 1999: GM-CSF treatment in patients with B-chronic lymphocytic leukemia. Leukemia and Lymphoma 32(3-4): 365-368
Zumberg, M.S.; Leather, H.L.; Nejame, C.; Meyer, C.; Wingard, J.R. 2002: GM-CSF versus G-CSF: engraftment characteristics, resource utilization, and cost following autologous PBSC transplantation. CytoTherapy 4(6): 531-538
Corliss, J. 1993: GM-CSF vital to some new vaccines. Journal of the National Cancer Institute 85(11): 851
Vaughan, M.M.; Moore, J.; Riches, P.G.; Johnston, S.R.; A'Hern, R.P.; Hill, M.E.; Eisen, T.; Ayliffe, M.J.; Thomas, J.M.; Gore, M.E. 2000: GM-CSF with biochemotherapy (cisplatin, DTIC, tamoxifen, IL-2 and interferon-alpha): a phase i trial in melanoma. Annals of Oncology: Official Journal of the European Society for Medical Oncology 11(9): 1183-1189
Pierri, I.; Clavio, M.; Beltrami, G.; Cavaliere, M.; Lanza, L.; Miglino, M.; Canepa, L.; Pietrasanta, D.; Ballerini, F.; Quintino, S.; Gatto, S.; Celesti, L.; Carrara, P.; Varese, P.; Gobbi, M. 1999: GM-CSF, ARA-C, VP-16 and idarubicin (GM-IVA), a short, and effective induction treatment for de novo AML, suitable for the elderly. Journal of Experimental and Clinical Cancer Research: Cr 18(1): 55-60
Pang, G.; Couch, L.; Batey, R.; Clancy, R.; Cripps, A. 1994: GM-CSF, IL-1 alpha, IL-1 beta, IL-6, IL-8, IL-10, ICAM-1 and VCAM-1 gene expression and cytokine production in human duodenal fibroblasts stimulated with lipopolysaccharide, IL-1 alpha and TNF-alpha. Clinical and Experimental Immunology 96(3): 437-443
Nonaka, M.; Nonaka, R.; Jordana, M.; Dolovich, J. 1996: GM-CSF, IL-8, IL-1R, TNF-alpha R, and HLA-DR in nasal epithelial cells in allergic rhinitis. American Journal of Respiratory and Critical Care Medicine 153(5): 1675-1681
Berclaz, P.-Y.; Shibata, Y.; Whitsett, J.A.; Trapnell, B.C. 2002: GM-CSF, via PU.1, regulates alveolar macrophage Fcgamma R-mediated phagocytosis and the IL-18/IFN-gamma -mediated molecular connection between innate and adaptive immunity in the lung. Blood 100(12): 4193-4200
Dranoff, G. 2002: GM-CSF-based cancer vaccines. Immunological Reviews 188: 147-154
LeVine, A.M.; Reed, J.A.; Kurak, K.E.; Cianciolo, E.; Whitsett, J.A. 1999: GM-CSF-deficient mice are susceptible to pulmonary group B streptococcal infection. Journal of Clinical Investigation 103(4): 563-569
Hikino, H.; Miyagi, T.; Hua, Y.; Hirohisa, S.; Gold, D.P.; Li, X.K.; Fujino, M.; Tetsuya, T.; Amemiya, H.; Suzuki, S.; Robb, L.; Miyata, M.; Kimura, H. 2000: GM-CSF-independent development of dendritic cells from bone marrow cells in the GM-CSF-receptor-deficient mouse. Transplantation Proceedings 32(7): 2458-2459
Pierri, I.; Clavio, M.; Miglino, M.; Cavaliere, M.; Pietrasanta, D.; Gobbi, M. 1999: GM-IVA, a short induction course for de novo acute myeloid leukemia, suitable for the elderly. Haematologica 84(6): 562-563
Dalia, A.; Neff, N.H.; Hadjiconstantinou, M. 1993: GM1 ganglioside improves dopaminergic markers of rat mesencephalic cultures treated with MPP+. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 13(7): 3104-3111
Laev, H.; Mahadik, S.P.; Bonheur, J.L.; Hernandez, N.; Karpiak, S.E. 1993: GM1 ganglioside reduces glutamate toxicity to cortical cells. Lowered LDH release and preserved membrane integrity. Molecular and Chemical Neuropathology 20(3): 229-243
Duchemin, A.M.; Neff, N.H.; Hadjiconstantinou, M. 1997: GM1 increases the content and mRNA of NGF in the brain of aged rats. Neuroreport 8(17): 3823-3827
Farooqui, T.; Kelley, T.; Coggeshall, K.M.; Rampersaud, A.A.; Yates, A.J. 1999: GM1 inhibits early signaling events mediated by PDGF receptor in cultured human glioma cells. Anticancer Research 19(6b): 5007-5013
Alvarez-Valiente, H.; Cuervo, N.; Dorado, J.; Menéndez, C. 1999: GM1 syndrome, generalized infantile gangliosidosis. Presentation of two cases. Revista de Neurologia 28(9): 926-928
Whitfield, P.; Johnson, A.W.; Dunn, K.A.; Delauche, A.J.; Winchester, B.G.; Franklin, R.J. 2000: GM1-gangliosidosis in a cross-bred dog confirmed by detection of GM1-ganglioside using electrospray ionisation-tandem mass spectrometry. Acta Neuropathologica 100(4): 409-414
Mundel, T.M. 2001: GM2-activator protein and vesicular transport in the connecting cells of kidney collecting tubules. Annals of Anatomy 183(1): 11
Denselow, J. 1982: GMAG and the teenage jackass. New Scientist 95(1320): 558-561
Schweiker, R.S. 1977: Support for Schweiker medical school admissions bill. Congressional Record: Proceedings and Debates of the . Congress. United States. Congress 123(147): S15310-5313
Lewin, R. 1977: GMAG falls foul of privacy constraints. New Scientist 76(1082): 683
Williamson, A.R. 1979: GMAG should look to NIH. Nature 277(5695): 346
Walgate, R. 1978: GMAG wants to stay on. Nature 273(5660): 259
Savage, P.; Waxman, J. 1996: PSA and prostate cancer diagnosis. European Journal of Cancer 32a (7): 1097-1099
Dyer, C. 1997: GMC accused of prejudicing doctors' defence. Bmj 315(7117): 1177
Dyer, O. 2001: GMC accuses surgeon of operating without consent. Bmj 323(7319): 952
Marcovitch 1999: Diagnose and be damned. Bmj 319(7221): 1376
Beecham, L. 1993: GMC advises doctors infected with HIV. Bmj 306(6891): 1547-1548
Beecham 1999: GMC advises doctors on seeking consent. Bmj 318(7183): 553a
Warden 1999: GMC advises trusts on governance. Bmj 318(7193): 1230a
Hunter, M. 2001: GMC agrees new structure. Bmj 323(7307): 250
Beecham, L. 1998: GMC approves new ethical guidance. Bmj 316(7144): 1556
Separovic, Z.-P. 1982: Compulsory hospitalization and human rights. American Journal of Social Psychiatry 2(4): 49-52
Savage, W. 2001: GMC assessment of Fergusson case was not at fault. Bmj 322(7282): 359-360
Burke, K. 2001: GMC chief retires as council votes for revalidation. Bmj 322(7298): 1323
Dyer, O. 2002: GMC clears Alder Hey doctor of dishonesty. Bmj 325(7375): 1258
Ferriman 2000: GMC decides on a new structure. Bmj 321(7274): 1434a
Dyer, C. 2001: GMC extends restrictions on Bristol heart surgeon. Bmj 322(7300): 1441
Dyer, O.; Chandnani, C.; Daengsvang, P.; Vishin, C. 1994: GMC finds GPs guilty of fraud. Bmj 308(6937): 1122
Dillner, L. 1991: GMC gets tough with fraudulent doctors. Bmj 303(6816): 1493
Anonymous 1994: GMC guidance on videos of patients. Bulletin of medical ethics No. 100: 5-6
Dyer, C. 2002: GMC hearing reveals how doctor won deal to have earlier inquiry documents destroyed. Bmj 325(7374): 1189
Brahams, D. 1993: GMC hearings governed by English law. Lancet 341(8846): 685
Smith, R. 1993: GMC in the dock again. Bmj 306(6870): 82
Beecham, L. 1997: GMC issues guidelines on circumcision. Bmj 314(7094): 1573
Diggory, P. 2002: GMC member forced to stand down from disciplinary panel. Colman's withdrawal from committee is issue of organisational governance. Bmj 324(7330): 168
Franks, W. 2002: GMC member forced to stand down from disciplinary panel. GMC should have protected Colman. Bmj 324(7330): 168-169
Dyer, C. 2000: GMC mishandled father's complaint. Bmj 321(7252): 11
Gibberd, F.B. 1998: GMC must not recommend abolition of united examining Board's examination. Bmj 316(7141): 1386-1387
Marcovitch, H. 2002: GMC must recognise and deal with vexatious complaints fast. Bmj 324(7330): 167-168
Brearley, S. 2001: GMC no longer favours folder of evidence for revalidation. Bmj 322(7289): 792
Watson, R. 2002: GMC opposes EU proposal to allow greater freedom of movement for doctors. Bmj 325(7368): 795
Dyer, C. 2000: GMC reprimands doctor for denigrating rival's service. Bmj 320(7233): 466
Kmietowicz, Z. 2001: GMC revalidation scheme passes first hurdle. Bmj 322(7297): 1267
Dyer, C. 2000: GMC ruling upheld despite records obtained "without consent". Bmj 320(7240): 957
Walsh, T. 1999: GMC should just continue its role as policeman and not try to improve clinical standards. Bmj 319(7222): 1437
Knight, S. 2000: GMC speeds up disciplinary action against doctors. Bmj 320(7233): 466
Baron 1998: Sir francis avery jones. Bmj 316(7145): 1678
Kmietowicz, Z. 2001: GMC steps up hearings to deal with rise in cases. Bmj 323(7305): 129
Hunter, M. 2001: GMC suspends former Alder Hey pathologist. Bmj 322(7282): 320
Beecham, L. 2000: GMC to consult on next stage of revalidation. Bmj 320(7247): 1425
Beecham, L. 2000: GMC to consult on structural changes. Bmj 321(7267): 980
Beecham, L. 1994: GMC to revise its ethics advice. Bmj 309(6964): 1251-1252
Dyer, C. 2002: GMC to send out new guidelines on end of life decisions. Bmj 324(7345): 1055
Beecham, L. 2000: GMC urged to be more radical. Bmj 321(7263): 725
Beecham 1999: GMC wants a tougher restoration procedure. Bmj 319(7221): 1319a
Anonymous 2000: GMC will get help to deal with more cases. Bmj 320(7246): 1411
Keable-Elliott, T. 1996: GMC's conduct committee is harsher to British than overseas doctors. Bmj 313(7058): 693
Grant, I.W. 1999: GMC's current proposals for revalidation are flawed. Bmj 319(7201): 53-54
Dyer, C.; Bewick, M.; Crockett, R.; Joyce, M. 1990: GMC's decision on "kidneys for sale. Bmj 300(6730): 961-962
Leslie, S.J.; Webb, D.J. 2001: GMC's guidance may inhibit research. Bmj 322(7302): 1601-1602
Aston, I. 1996: GMC's guidance on HIV infection and AIDS is useful. Bmj 313(7059): 751-752
Wakeford, R. 2000: GMC's proposals for revalidation would not be accurate, economical, or fair. Bmj 321(7270): 1220
Hayes, S. 2001: GMC's proposals for revalidation. Appraisal is helpful only if done well. Bmj 322(7282): 358; Author Reply 359
Jolly, B.; McAvoy, P.; Southgate, L. 2001: GMC's proposals for revalidation. Effective revalidation system looks at how doctors practise and quality of patients' experience. Bmj 322(7282): 358-359
Newble, D. 2001: GMC's proposals for revalidation. Purpose of revalidation process must be agreed on. Bmj 322(7282): 358; Author Reply 359
Plum, F.; Levy, D.E. 1979: Outcome from severe neurological illness; should it influence medical decisions?. Ciba Foundation Symposium No. 69(6519): 267-277
Brahams, D. 2000: GMC's sifting and investigation of complaints must be "transparent". Lancet 356(9224): 145
Smith, R. 2001: GMC: approaching the abyss. Bmj 322(7296): 1196
Arnold, P. 2001: GMC: approaching the abyss. Australia may show way foward for the United Kingdom. Bmj 322(7302): 1600
Gray, D.P. 2001: GMC: approaching the abyss. GMC: keeping feet on firm ground. Bmj 322(7302): 1599-1600
Forbes, G.; Leggate, S.; Nicholls, B.; Robinson, C.; Shaw, J. 2001: GMC: approaching the abyss. people should be wary of the alternative. Bmj 322(7302): 1599
Keighley, B.; Alberti, G.; Chicholm, J.; Fradd, S.; Jackson, B.; MacSween, R.; Meldrum, H.; Pickersgil, D.; Pringle, M. 2001: GMC: approaching the abyss. Preservation is well worth the effort. Bmj 322(7302): 1599
Bhushan, M.; McElhone, K.; Griffiths, C.E. 1998: GMDP and psoriasis. Lancet 352(9143): 1857
Collins, J.; Alderson, P.O.; Amsel, S. 2000: GME core curriculum: a pilot program in radiology. Graduate medical education. Academic Medicine: Journal of the Association of American Medical Colleges 75(5): 547-548
Hagemeier, G. 1997: Uniform standards are basic building blocks for Electronic Data Interchange. Healthcare Edi Coalition. Journal of Healthcare Resource Management 15(6): 26
Johnson, S.J. 1994: GME financing: a well-kept secret. Nursing Management 25(4): 43-46
Wagner, L. 1992: GME payment plan aims to aid primary care. Modern Healthcare 22(31): 10
Stevens, D.P. 1997: GME reform needs visionary academic leadership. Academic Medicine: Journal of the Association of American Medical Colleges 72(11): 986-987
Gross, J.E. 1988: GME: at the crossroads. A viewpoint from OHMA (Office of Health and Medical Affairs). Michigan Hospitals 24(8): 20 22-23 25
Anonymous 1988: GME: raising awareness about financing. A viewpoint from GDAHC (Greater Detroit Area Health Council). Michigan Hospitals 24(8): 21 27-9
Peterson, S.E.; Rodin, A.E. 1983: GMENAC report on U.S. physician manpower policies: recommendations and reactions. Health Policy and Education 3(4): 337-349
Bowman, M.A. 1985: GMENAC revisited: medical manpower in the late 80s. Journal of Medical Practice Management: Mpm 1(1): 66-72
Cawley, J.F.; Stein, W.A. 1983: GMENAC revisited: questionable assumptions and conflicting data. Physician Assistant 7(3): 161-162
Steinwachs, D. 1983: GMENAC's projection of a future physician surplus. Implications for HMOs. Group Health Journal 4(1): 7-11
Donaldson, W.F. 1981: GMENAC, the numbers game. Bulletin of the American College of Surgeons 66(3): 12-18
Cotenoff, S. 1999: Body positive: a history of service. Body Positive 12(7): 14; 18-25
Ouellette, S.C.; Cassel, J.B.; Maslanka, H.; Wong, L.M. 1995: GMHC volunteers and the challenges and hopes for the second decade of AIDS. Aids Education and Prevention: Official Publication of the International Society for Aids Education 7(5 Suppl): 64-79
Johnsson, J. 1988: GMIS (Gabrieli Medical Information Systems) software flags inappropriate billings, medical procedures. Contract Healthcare 1988: 28-29
Knutson, K.L. 2002: GMK (Progenics Pharmaceuticals). Current Opinion in Investigational Drugs 3(1): 159-164
Klein, A.E.; Rocci, M.L. 1995: GMP criteria for retest and failure analysis. Handling out-of-specification results in the pharmaceutical quality control laboratory. Quality Assurance 4(4): 247-251
East, B. 1988: GMP production documentation. Journal of Sterile Services Management 5(5): 7-9
Gibson, G.J.; Seaton, A. 2000: GMS's advice in Serious Communicable Diseases. Is consent to testing necessary for tuberculosis in the same way as for HIV infection?. Bmj 320(7251): 1727
Bradbrook, J.; Carmi, M.; Danby, J.; Fawdry, R.; Fletcher, J.; Gill, D.; Jackson-Baker, A.; Jewell, D.; McKenzie, M.; Noble, A.; Porter, R.; Seaman, B.; Smith, L.; Young, G. 1996: GMSC's advice on intrapartum care is unhelpful. Bmj 312(7035): 910-911
Thomas, P.D. 1996: GMSC's advice on intrapartum care. Committee is out of touch with needs of profession. Bmj 313(7052): 305
Zander, L. 1996: GMSC's advice on intrapartum care. GMSC's advice differs from royal college's. Bmj 313(7052): 305
Wu, C.C.; Taylor, R.S.; Lane, D.R.; Ladinsky, M.S.; Weisz, J.A.; Howell, K.E. 2000: GMx33: a novel family of trans-Golgi proteins identified by proteomics. Traffic 1(12): 963-975
Ahmed, S.F.; Dixon, P.H.; Bonthron, D.T.; Stirling, H.F.; Barr, D.G.; Kelnar, C.J.; Thakker, R.V. 1998: GNAS1 mutational analysis in pseudohypoparathyroidism. Clinical Endocrinology 49(4): 525-531
Ahmed, S.Faisal.; Barr, D.G.D.; Bonthron, D.T. 2002: GNAS1 mutations and progressive osseous heteroplasia. New England Journal of Medicine 346(21): 1669-1671
Craven, C. 2002: GNOSIS program pays off. Nursing Management 33(8): 15-16
Overman, S.; Pellegrino, E.D. 1981: Physician-educator emphasizes value-oriented education. Hospital Progress 62(12): 18
Ott, E.; Leiby, J.; Kilgore, E. 1983: GNP effectiveness in a rehabilitation center. Journal of Long Term Care Administration 11(3): 30-31
Edgell, J. 1983: GNP role development: problems and potentials. Journal of Long Term Care Administration 11(3): 17-18
Gamroth, L. 1983: GNP role development: what makes the difference?. Journal of Long Term Care Administration 11(3): 15-16
Karnowski, D.L. 1983: GNP--the bloom of Rose Arbor Manor. Journal of Long Term Care Administration 11(3): 41-45
Enlow, C. 1983: GNP: curriculum and training. Journal of Long Term Care Administration 11(3): 5-9
Wolanin, M.O. 1983: GNP: the right person at the right time. Journal of Long Term Care Administration 11(3): 3-4
Williams, L. 1983: GNPs fill care gap, says California study. Today's Nursing Home 4(10): 1; 6
Scott, L. 1996: GNYHA awards first distribution pact. Modern Healthcare 26(3): 16
Hallam, K. 1998: GNYHA to sue HHS over fraud probe. Modern Healthcare 28(15): 3; 8
Morrissey, J. 1995: GNYHA, insurers to develop CHIN. Modern Healthcare 25(31): 15
Cassetta, R. 1994: GNs reap benefits of computerized NCLEX, but at what cost?. American Nurse 26(9): 14; 19
Resnicow, K.; Yaroch, A.L.; Davis, A.; Wang, D.T.; Carter, S.; Slaughter, L.; Coleman, D.; Baranowski, T. 2000: GO GIRLS!: results from a nutrition and physical activity program for low-income, overweight African American adolescent females. Health Education and Behavior: the Official Publication of the Society for Public Health Education 27(5): 616-631
Lanzilotti, S.S. 2001: GO-4 ALS. Mini ALS units take Honolulu EMS by storm. Jems: a Journal of Emergency Medical Services 26(12): 52-53
Nagarajan, R. 1996: Landholding and fertility relationship: a review of the empirical evidence. Artha Vijnana: Journal of the Gokhale Institute of Politics and Economics Poona 38(3): 274-305
Martin, S.D. 2000: Striking nurses win from coast to coast. American Nurse 34(2): 8
O'Brien, E.A.; Badidi, E.; Barbasiewicz, A.; deSousa, C.; Lang, B.Franz.; Burger, G. 2003: GOBASE--a database of mitochondrial and chloroplast information. Nucleic Acids Research 31(1): 176-178
Shimko, N.; Liu, L.; Lang, B.F.; Burger, G. 2001: GOBASE: the organelle genome database. Nucleic Acids Research 29(1): 128-132
Paar; Vorkapic; Dieperink 1992: GOE-type energy level statistics and regular classical dynamics for rotational nuclei in the interacting boson model. Physical Review Letters 69(15): 2184-2187
Heinrich, H.; Nelson, K.; Moll, G.H.; Rothenberger, A. 1998: GOFI--a neurofeedback system for child and adolescent psychiatry. Biomedizinische Technik. Biomedical Engineering 43 Suppl. 3: 67-71
Abecasis, G.R.; Cookson, W.O. 2000: GOLD--graphical overview of linkage disequilibrium. Bioinformatics 16(2): 182-183
Kofránek, J.; Vu, L.D.; Snáselová, H.; Kerekes, R.; Velan, T. 2001: GOLEM--multimedia simulator for medical education. Studies in Health Technology and Informatics 84(Part 2): 1042-1046
Verloes, A.; Lesenfants, S.; Jamar, M.; Dideberg, V.; Herens, C. 2000: GOMBO syndrome: another "pseudorecessive" disorder due to a cryptic translocation. American Journal of Medical Genetics 95(2): 185-186
Siwicki, B. 1992: GOOD campaign generates ideas. Healthcare Financial Management: Journal of the Healthcare Financial Management Association 46(6): 105; 107
Weissenstein, E. 1995: GOP begins detailing Medicare plans. Modern Healthcare 25(37): 2
Wagner, L. 1992: GOP begins to bash reform proposals. Modern Healthcare 22(3): 24
Childs, N. 1999: GOP bill includes LTC insurance incentives. Provider 25(9): 19-20
Weissenstein, E. 1992: GOP blesses Bush plan, bashes Democrats' plan. Modern Healthcare 22(34): 6
Gardner, J. 1999: GOP budget blueprint doesn't erase cuts. Modern Healthcare 29(16): 3; 6
Hallam, K. 1999: GOP delays vote on doc antitrust bill. Insurers, employers, hospitals have lobbied against the bill, saying it will increase costs. Modern Healthcare 29(45): 6
Gardner, J.; Pallarito, K. 1995: GOP details Medicare plan. Modern Healthcare 25(39): 4; 8
Gardner, J. 2000: GOP embraces Bush, provider views. Modern Healthcare 30(33): 3; 12
Weissenstein, E. 1995: GOP floats ideas for health reform. Modern Healthcare 25(6): 2-3
Weissenstein, E. 1995: GOP funding plan draws states' concern. Modern Healthcare 25(10): 28
Weissenstein, E. 1995: GOP governor opposition jeopardizes Senate plan. Modern Healthcare 25(42): 36
Coffey, R.J. 1985: Computerized models for strategic planning and marketing. Health Care Strategic Management 3(3): 8-11
Anonymous 1999: GOP lawmakers seek a second review of dentist's case. Aids Policy and Law 14(9): 7
Weissenstein, E. 1995: GOP lays out red carpet again for Perot, this time on Medicare. Modern Healthcare 25(37): 42
Weissenstein, E. 1994: GOP leaders drop overhaul strategy. Modern Healthcare 24(49): 6
Weissenstein, E. 1997: GOP moves toward restoring immigrant Medicaid funds. Modern Healthcare 27(19): 30
Wagner, L.; Weissenstein, E. 1993: GOP offers its own health plans. Modern Healthcare 23(38): 2
Gardner, J.; Weissenstein, E. 1996: GOP offers new plan for Medicare, Medicaid. Modern Healthcare 26(20): 5
Weissenstein, E. 1992: GOP optimistic about its health reform plan. Modern Healthcare 22(24): 19
Weissenstein, E. 1995: GOP outlines its plan for Medicare options. Modern Healthcare 25(16): 2
Gardner, J.; Weissenstein, E.; Moore, J.D.; Pallarito, K. 1995: GOP picks up AMA support as Medicare plan advances. Modern Healthcare 25(42): 2; 16
Weissenstein, E. 1995: GOP plan sees 5% rise in Medicare hospital payments. Modern Healthcare 25(38): 3
Weissenstein, E. 1996: GOP plan separates budget bills. Modern Healthcare 26(17): 17
Gardner, J. 1995: GOP plan would bundle hospital, post-acute care. Modern Healthcare 25(23): 8
Lutz, S. 1995: GOP plans would boost for-profits' capital pay. Modern Healthcare 25(41): 2-3
Weissenstein, E. 1998: GOP releases final reform proposals. Modern Healthcare 28(29): 2-3; 14
Gardner, J. 1995: GOP senators fight long-term-care plans. Modern Healthcare 25(43): 22
Gardner, J. 1995: GOP spending bills would scrap plans for 2 VA hospitals. Modern Healthcare 25(29): 3
Weissenstein, E. 1995: GOP still split on Medicaid. Modern Healthcare 25(38): 14
Wagner, L. 1991: GOP takes heed, talks up reform. Modern Healthcare 21(47): 4
Bell, C.W. 1995: GOP talks tough, but will act slowly. Modern Healthcare 25(7): 62
Gardner, J. 1994: GOP targets healthcare spending. Modern Healthcare 24(47): 49
Gardner, J.; Weissenstein, E. 1996: GOP to pitch insurance reform. Modern Healthcare 26(10): 2; 16
Weissenstein, E. 1995: GOP vows to continue fight for balanced-budget measure. Modern Healthcare 25(10): 4
Weissenstein, E. 1995: GOP wields budget ax on healthcare. Modern Healthcare 25(10): 76
McLaughlin, N. 1995: GOP won't reach goals for cuts in Medicare, ex-CBO chief says. Modern Healthcare 25(32): 26
Anonymous 1995: GOP's proposed Medicare antitrust exemptions dangerous, feds warn. Healthcare Systems Strategy Report 12(22): 11-12
Weissenstein, E. 1996: GOP, Democratic governors clash over Medicaid reform. Modern Healthcare 26(13): 8
Weissenstein, E. 1995: GOP, Democrats take Medicare battle on road. Modern Healthcare 25(33): 2
Dodds, S.R.; Cowen, A.R.; Chant, A.D. 1994: GORA: a scoring system for the quantification of risk of graft occlusion. Annals of the Royal College of Surgeons of England 76(4): 286
Ache, P.; Becker, D.; Ivashikina, N.; Dietrich, P.; Roelfsema, M.R.; Hedrich, R. 2000: GORK, a delayed outward rectifier expressed in guard cells of Arabidopsis thaliana, is a K(+)-selective, K(+)-sensing ion channel. Febs Letters 486(2): 93-98
Sell, D.; Harding, A.; Grunwell, P. 1999: GOS.SP.ASS.'98: an assessment for speech disorders associated with cleft palate and/or velopharyngeal dysfunction (revised). International Journal of Language and Communication Disorders 34(1): 17-33
Wright, A.F. 1996: GP 2000: a general practitioner for the new millennium. British Journal of General Practice: the Journal of the Royal College of General Practitioners 46(402): 4-5
Bevan, N.S.; McArthur, C.J.; McKeating, J.B. 2000: GP 2000: what's happening in general practice?. Journal of the Royal Naval Medical Service 86(1): 20-26
Ravna, A.W.; Schrøder, K.E.; Edvardsen, O. 1999: A World Wide Web-service to aid the development of AMBER parameters using analogy to standard parameters. Computers and Chemistry 23(5): 435-437
Kleiman, N.S. 1999: GP IIb/IIIa antagonists. Clinical experience and potential uses in cardiology. Drugs in R&d 1(5): 361-370
Chew, D.P.; Moliterno, D.J. 2001: GP IIb/IIIa inhibitors in coronary artery disease management: what the latest trials tell us. Cleveland Clinic Journal of Medicine 68(12): 1017-1023
Anonymous 1999: GP IIb/IIIa inhibitors: an evidence-based approach to their use. Medical Management Network 7(3): 5-9
Francuz, T. 2001: GP IIb/IIIa receptor antagonists--molecular and clinical aspects. Postepy Higieny i Medycyny Doswiadczalnej 55(3): 419-432
Potrykus, C. 1993: GP alignment threatens care. Health Visitor 66(2): 44-45
Crichton, B.; Green, M. 2002: GP and patient perspectives on treatment with non-steroidal anti-inflammatory drugs for the treatment of pain in osteoarthritis. Current Medical Research and Opinion 18(2): 92-96
Egberts, J.; Grondhuis Palacios, L.A.; van der Wielen, G.J. 2018: A man with a palpable node on the prostate. Nederlands Tijdschrift Voor Geneeskunde 162
Colebatch, T. 1995: GP autopsies. Australian Family Physician 24(11): 2146
Malcolm, L. 1997: GP budget holding in new Zealand: lessons for Britain and elsewhere?. Bmj 314(7098): 1890-1892
Weiner, J.P.; Ferriss, D.M. 1990: GP budget holding in the United Kingdom: learning from American HMOs. Health Policy 16(3): 209-220
Shapiro, J.; Smith, J.; Walsh, N. 1996: GP commissioning. Fluid drives. Health Service Journal 106(5509): 28-31
Wilson, M.; MacCarthy, B. 1994: GP consultation as a factor in the low rate of mental health service use by Asians. Psychological Medicine 24(1): 113-119
York, J. 1997: GP cooperatives. can improve lives of doctors and care of patients. Bmj 314(7085): 975
Rawlinson, J. 1997: GP cooperatives. Doctors must listen to criticism. Bmj 314(7085): 975
Robertson, D.A. 1997: GP cooperatives. Don't serve rural patients well. Bmj 314(7085): 976
Holmes, P. 1997: GP cooperatives. More points must be addressed. Bmj 314(7085): 976
McKenna, K. 1997: GP cooperatives. Offer a vehicle for change. Bmj 314(7085): 976
Lattey, N. 1997: GP cooperatives. Unity of approach to out of hours care is needed. Bmj 314(7085): 975-976
Bridges-Webb, C. 2000: GP core business. Australian Family Physician 29(9): 821
Sturmberg, J.P.; Reid, S. 2001: GP corporatisation. Medical Journal of Australia 175(8): 448
Little, P. 1998: GP documentation of obesity: what does it achieve?. British Journal of General Practice: the Journal of the Royal College of General Practitioners 48(426): 890-894
Kmietowicz, Z. 2001: GP dossier says patients getting "second rate" service. Bmj 322(7296): 1197
Huntington, J. 1994: GP education. Bottom of the class?. Health Service Journal 104(5419): 22-24
Dyer, C. 1999: GP faces 15 charges of murder. Bmj 319(7215): 938
Guthrie, B.; Stinton, F.; Reilly, G.; Barton, S. 1994: GP facilitators and HIV infection. GPs should be involved early. Bmj 308(6927): 538-539
Davis, B. 1994: GP facilitators and HIV infection. Heterosexual infection less common than other routes. Bmj 308(6927): 538
Lempp, H.; Rink, E. 1994: GP facilitators and HIV infection. other health professionals can be facilitators. Bmj 308(6927): 539
Grun, L.; Murray, E. 1994: GP facilitators and HIV infection. Shared care better for GPs and specialists. Bmj 308(6927): 538
Dyer, O.; Bochsler, J. 1998: GP found guilty of forging trial consent forms. Bmj 317(7171): 1475
Dowrick, C.F.; Bellón, J.A.; Gómez, M.J. 2000: GP frequent attendance in Liverpool and Granada: the impact of depressive symptoms. British Journal of General Practice: the Journal of the Royal College of General Practitioners 50(454): 361-365
Gill, D.; Dawes, M.; Sharpe, M.; Mayou, R. 1998: GP frequent consulters: their prevalence, natural history, and contribution to rising workload. British Journal of General Practice: the Journal of the Royal College of General Practitioners 48(437): 1856-1857
Dillner, L. 1996: GP fundholder reported to GMC. Bmj 312(7027): 334
Cole, A. 1994: GP fundholders. Prescription for unequal opportunities. Health Visitor 67(7): 221-222
Whynes, D.K.; Baines, D.L.; Tolley, K.H. 1995: GP fundholding and the costs of prescribing. Journal of Public Health Medicine 17(3): 323-329
Whynes, D.K.; Baines, D.L.; Tolley, K.H. 1997: GP fundholding and the costs of prescribing: further results. Journal of Public Health Medicine 19(1): 18-22
Dean, M. 1994: GP fundholding steams ahead. Lancet 344(8930): 1145
Fewtrell, C. 1994: GP fundholding--half a good policy. Health Services Management 90(7): 13; 15
Jackson, C. 1993: GP fundholding. a tale of two teams. Health Visitor 66(2): 41
Kline, R. 1994: GP fundholding. Doctor should know better. Health Visitor 67(6): 210
Naughton, B. 1993: GP fundholding. Funds of opportunity. Nursing Times 89(17): 62-64
Armstrong, L. 1993: GP fundholding. Mind over matter. Nursing Times 89(50): 29-30
Norman, A. 1993: GP fundholding. Vested interests. Nursing Times 89(50): 26-29
Tod, D. 1995: GP fundholding: fact or fiction. British Journal of Hospital Medicine 54(9): 471-472
Gill, J. 1994: GP fundholding: fair shares. Nursing Times 90(3): 48-50
Owen, C. 1996: GP gender balance. Australian Family Physician 25(5): 623
Verheij, R.A.; De Bakker, D.H.; Reijneveld, S.A. 2001: GP income in relation to workload in deprived urban areas in the Netherlands. Before and after the 1996 pay review. European Journal of Public Health 11(3): 264-266
Beech, B.A.L. 2002: GP involvement in child protection. British Journal of General Practice: the Journal of the Royal College of General Practitioners 52(481): 677-678
Eskin, F. 1979: GP isolation can mean ineffective DMT participation. Health and Social Service Journal 89(4624): 35-36
Sibbald, B.; Enzer, I.; Cooper, C.; Rout, U.; Sutherland, V. 2000: GP job satisfaction in 1987, 1990 and 1998: lessons for the future?. Family Practice 17(5): 364-371
Crozier, A.M. 1996: GP learning needs. Australian Family Physician 25(2): 124-125
Jiwa, M.; Burr, J. 2002: GP letter writing in colorectal cancer: a qualitative study. Current Medical Research and Opinion 18(6): 342-346
Dyer 1999: GP loses libel action. Bmj 318(7197): 1510b
Fraser, S.; Shah, P.; Khaw, P.T. 1998: GP management of glaucoma. Practitioner 242(1593): 855-858
Lovell, G.A.; Hay, P.J. 2003: GP meets the psychiatrist. Medical Journal of Australia 178(2): 93
Waddington, D. 1996: GP monitoring of lithium levels. British Journal of Psychiatry: the Journal of Mental Science 168(3): 383
Chambers, R.; Fieldhouse, R.; O'Connell, S. 1998: GP non-principals' education: let's improve access for our flexible friends. British Journal of General Practice: the Journal of the Royal College of General Practitioners 48(434): 1551-1552
Black, N. 1982: GP obstetrics: better than expected. Health and Social Service Journal 92(4796): 592-594
Dyer, C.; Moor, D. 1999: GP on trial for murder. Bmj 318(7191): 1095
Cupples, M.; Reilly, P.; Bradley, T.; Irvine, H. 2000: GP opportunities for teenage health promotion. British Journal of General Practice: the Journal of the Royal College of General Practitioners 50(456): 581
Hobday, P. 1998: GP out of hours service. British Journal of General Practice: the Journal of the Royal College of General Practitioners 48(435): 1703
Munday, D.; Douglas, A.; Carroll, D. 1999: GP out-of-hours cooperatives and the delivery of palliative care. British Journal of General Practice: the Journal of the Royal College of General Practitioners 49(443): 489
Rosser, J. 1998: GP payments for maternity care. Practising Midwife 1(6): 4-5
Lim, A.C.; See, A.; Shumack, S.P. 2001: GP postgraduate dermatology training. Australian Family Physician 30(6): 526-527
Evans, J.; Lambert, T.; Goldacre, M. 2002: GP recruitment and retention: a qualitative analysis of doctors' comments about training for and working in general practice. Occasional Paper 2002(83): Iii-Vi 1-33
Burbach, F.R.; Harding, S. 1997: GP referral letters to a community mental health team: an analysis of the quality and quantity of information. International Journal of Health Care Quality Assurance Incorporating Leadership in Health Services 10(2-3): 67-72
Hugo, P.; Kendrick, T.; Reid, F.; Lacey, H. 2000: GP referral to an eating disorder service: why the wide variation?. British Journal of General Practice: the Journal of the Royal College of General Practitioners 50(454): 380-383
Ghiacy, S. 1995: GP referrals. Primary teachers. Health Service Journal 105(5460): 27
Bannon, M.J.; Carter, Y.H.; Jackson, N.R. 2000: GP registrars need training in child abuse and neglect. Medical Education 34(1): 77-78
Dyer, C. 2000: GP reprimanded for testing patients for HIV without consent. Bmj 320(7228): 135
McCartney, P.J. 1996: GP screening for glaucoma. Australian and New Zealand Journal of Ophthalmology 24(2): 162-163
Woodcock, A.; White, P.; Smith, H.; Coles, C.; Campion-Smith, C.; Stannard, T. 2000: GP selection of postgraduate education courses has implications for colleagues: messages for course providers and for those writing practice professional development plans. British journal of general practice: the journal of the Royal College of General Practitioners 50(459): 785-790
Houston, M. 2002: GP services in Ireland are not adequate to cope with rise in number of old people. Bmj 325(7374): 1194
French, D.P.; McKinley, R.K.; Hastings, A. 2001: GP stress and patient dissatisfaction with nights on call: an exploratory study. GP stress and patient satisfaction. Scandinavian Journal of Primary Health Care 19(3): 170-173
Dyer, O. 2002: GP struck off after offering to "fix" kidney sale. Bmj 325(7363): 510
Dyer, O. 2001: GP struck off for agreeing to perform female circumcision. Bmj 322(7277): 9
Dyer, O. 1996: GP struck off for fraud in drug trials. Bmj 312(7034): 798
Rouse, A. 1999: GP surgeries were hard to contact over Christmas. Bmj 318(7195): 1422
Morris, C.J.; Cantrill, J.A.; Weiss, M.C. 2001: GP survey response rate: a miscellany of influencing factors. Family Practice 18(4): 454-456
Dyer, O. 2003: GP suspended for enrolling patients in drug trials without consent. Bmj 326(7384): 304
McKinstry, B.; Walker, J. 2002: GP telephone consultations. British Journal of General Practice: the Journal of the Royal College of General Practitioners 52(480): 585-586
Agreus, L.; Xia, H.H.; Talley, N.J. 1997: GP testing for Helicobacter pylori. Alimentary Pharmacology and Therapeutics 11(6): 1143
Gonzalez, A.F. 1977: GP to South Africa's blacks. American Medical News 20(50): Suppl: 10-11
Turner, C. 1993: GP trainees. British Journal of General Practice: the Journal of the Royal College of General Practitioners 43(376): 479-480
Power, D.; White, M. 1993: GP trainees and MMR immunisation. Irish Medical Journal 86(1): 15-16
Higgins, E.M.; Fuller, L.C.; du Vivier, A.W.; Tovey, D. 1997: GP training in dermatology. British Journal of General Practice: the Journal of the Royal College of General Practitioners 47(422): 594
Ferguson, C.; Brown, M.; McKillop, D.; Bradley, S. 1994: GP training--screen test. Health Service Journal 104(5405): 22-23
Boston, N.; Hood, S.; Boynton, P. 2001: GP use and views of an inner-city GP unit. British Journal of General Practice: the Journal of the Royal College of General Practitioners 51(463): 139
Goulding, C.; Hamilton, W. 2000: GP use of anti-D. British Journal of Family Planning 26(2): 116
Weller, D.; McGorm, K. 1999: GP versus hospital follow up for cancer patients. Is the choice based on evidence?. Australian Family Physician 28(4): 356-359
Wirth, K.E. 1997: GP vs. specialist. Journal of the American Dental Association 128(9): 1208
Carnall 2000: GP websites. Bmj 320(7227): 126b
Bollen, M. 1996: GP workforce numbers. Australian Family Physician 25(5): 625-626
Summerton, N. 1996: GP's management of acute back pain. Is evidence based. Bmj 312(7044): 1480
Ward, P.; Carvell, J. 1996: GP's management of acute back pain. Referral letters are inadequate. Bmj 312(7044): 1481
Elliston, P. 1996: GP's management of acute back pain. Research on which to base guidelines is possible in primary care. Bmj 312(7044): 1481
Stokes, T.; Bhaduri, S.; Schober, P.; Shukla, R. 1997: GP's management of genital Chlamydia: a survey of reported practice. Family Practice 14(6): 455-460
Frain, J. 1994: GP's opinions about provision of intrapartum care. Bmj 309(6963): 1231
Bateman, C. 2002: GP's vision kick-starts palliative training. South African Medical Journal 92(12): 936-937
Soriani, M.; Freiburghaus, A.U. 1997: GP-2 is the major ATP-binding protein of pig pancreatic zymogen granule membranes. Pancreas 14(1): 102-103
Liu, H.W.; Lin, Y.C.; Chao, C.F.; Chang, S.Y.; Sun, G.H. 2000: GP-83 and GP-39, two glycoproteins secreted by human epididymis are conjugated to spermatozoa during maturation. Molecular Human Reproduction 6(5): 422-428
Somers, G.T. 1999: GP-based emergency response in rural areas: is there a need?. Australian Journal of Rural Health 7(2): 104-108
Allen, C.; Brown, N. 1996: GP-based memory aid group benefits clients and carers. Nursing Times 92(40): 42-44
Henning, R. 1994: GP-hospice interaction. when should patients be referred?. Australian Family Physician 23(7): 1242-1245
Anonymous 1999: GP11b/111a receptor antagonists. Better prognoses in acute coronary syndromes. Krankenpflege Journal 37(5): 180-181
Carael, M.; Mertens, T. 1995: GPA finalizes tools to evaluate AIDS care. Global Aidsnews: the Newsletter of the World Health Organization Global Programme on Aids 1995(3-4): 10-11
Pratinidhi, A.; Shrotri, A.; Shah, U. 1994: Risk of teen-age pregnancy in a rural community of India. Indian Journal of Maternal and Child Health: Official Publication of Indian Maternal and Child Health Association 1(4): 134-138
Jain, B.K. 1994: Vitamin requirements of very low birth weight infants: a review. Indian Journal of Maternal and Child Health: Official Publication of Indian Maternal and Child Health Association 5(2): 46-49
Hartigan, P.; Wiseman, T. 1993: Working with NGOs: PAHO's approach. Global Aidsnews: the Newsletter of the World Health Organization Global Programme on Aids 3: 17-18
Anonymous 2002: GPC Biotech receives Orphan Medicinal Product Designation. Expert Review of Anticancer Therapy 2(3): 246
Carnall 1999: HIV testing in pregnancy. Bmj 319(7219): 1275a
Birch 1999: Life without disease: the pursuit of medical utopia. Bmj 318(7185): 742
Hanton; Liu 2000: GPC separation of polymer samples for MALdi analysis. Analytical Chemistry 72(19): 4550-4554
Crossley, R. 2003: GPCRs come of age in San Diego. Drug Discovery Today 8(1): 19-20
Vella, F. 1994: GPEP report recommends traditional and nontraditional approaches. Academic Medicine: Journal of the Association of American Medical Colleges 69(1): 36
Nagamune, K.; Kinoshita, T. 2002: GPi biosynthetic pathway as a target for antiprotozoan drugs. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 47(1): 30-36
Komiya, T.; Hirashima, T.; Kikui, M.; Fukuoka, M.; Ohno, A.; Kawase, I. 1999: GPI-anchored molecule-like protein (GML) expression in non-small cell lung cancer (NSCLC). Anticancer Research 19(5b): 4315-4319
Ikezawa, H. 1999: GPI-anchored proteins. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 44(8 Suppl): 1321-1328
Nurden, P. 2001: GPIIb-IIIa inhibitors. Transfusion Clinique et Biologique: Journal de la Societe Francaise de Transfusion Sanguine 8(2): 114-122
Hofmann, L.V.; Razavi, M.; Arepally, A.; Reginelli, J.P.; Resar, J.; Geschwind, J.F.; Corl, F. 2001: GPIIb-IIIa receptor inhibitors: what the interventional radiologist needs to know. Cardiovascular and Interventional Radiology 24(6): 361-367
Nordt, T.K.; Peter, K.; Bode, C. 2001: GPIIb/IIIa blockers for optimizing thrombolysis in acute myocardial infarct. Herz 26(Suppl 1): 42-45
Ikeda, Y. 2000: GPIIb/IIIa inhibitor. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 45(6 Suppl): 1174-1181
Auguadro, C.; Mortara, A.; Priori, S.G.; Specchia, G. 2002: GPIIb/IIIa polymorphism in patients with myocardial infarction. Acta Cardiologica 57(1): 32-33
Peri, S.; Steen, H.; Pandey, A. 2001: GPMAW--a software tool for analyzing proteins and peptides. Trends in Biochemical Sciences 26(11): 687-689
DeJohn, P. 2000: GPO deals still golden; compliance is the key. Hospital Material Dollar Sign Management 25(10): 1; 9-1,12
DeJohn, P. 1999: GPO hopes new name will end 'identity crisis'. Hospital Material Dollar Sign Management 24(7): 1; 8-9
Becker, C. 2001: GPO maverick. MedAssets now a Georgia peach in feisty field of hospital cooperatives. Modern Healthcare 31(21): 28
Barlow, R.D. 2002: GPO or go it alone? There's a third way. Or Manager 18(6): 11-13
Gouveia, W.A. 2002: GPO reform. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 59(10): 919
Norman, E. 1997: GPO survival strategies. Journal of Healthcare Resource Management 15(2): 24-27
Perry, P.A. 1990: GPO's activity in medical waste management grows. Hospital Material Dollar Sign Management 15(12): 1; 12
Taylor, K.S. 1994: GPOs and alliances adapt to health care's changing needs. Hospitals and Health Networks 68(9): 62
Johnson, D.E. 1995: GPOs and materials managers must adapt to integrated systems. Hospital Material Dollar Sign Management 20(11): 9; 17
Decker, R. 1991: GPOs and their product evaluation committees should be aware of their legal liabilities. Hospital Material Dollar Sign Management 16(5): 22-23
DeJohn, P. 1997: GPOs celebrate end to FASA price list extension (for now). Hospital Material Dollar Sign Management 22(12): 1; 12-13
Becker, C. 2002: GPOs do some explaining. Concerned about conflicts of interest, a Senate judiciary committee gives GPOs 90 days to create a code of conduct. Modern Healthcare 32(18): 6-7 16 1
Brady, L. 1994: GPOs driving headlong toward fork in the road. Hospital Material Dollar Sign Management 19(12): 9; 17
Veasey, N. 1994: Larger hospitals show greatest increase in food service non-salary expenses. Hospital Material Dollar Sign Management 19(4): 14; 18
Weiss, J. 1996: GPOs must redefine the term "benefit" to remain viable. Hospital Material Dollar Sign Management 21(2): 3
Johnson, D.E.L. 2002: GPOs need new policies and strategies. Hospital Material Dollar Sign Management 27(6): 2-4; 1
Anonymous 1999: GPOs offering reuse agreements. Or Manager 15(5): 17 20
DeJohn, P. 1999: GPOs rushing to Web faster than hospitals can get online. Hospital Material Dollar Sign Management 24(1): 1; 9
Anonymous 2002: GPOs take steps toward codes of conduct. Or Manager 18(9): 10
Hensley, S. 1999: GPOs under pressure to deliver. Purchasing volume climbs, but Internet firms and independents are challenging the large groups. Modern Healthcare 29(38): 38-40 42 44-7
Anonymous 1997: GPOs will need flexibility to stay ahead of IDNs. Hospital Material Dollar Sign Management 22(12): 9-11
Johnson, D.E.L. 2002: GPOs' boards need new policies and strategies. Health Care Strategic Management 20(5): 2-3
Becker, C. 2002: GPOs' draft conduct code faces little guys, lawmakers. Working document stays mostly silent on issues of product bundling and sole-source contracting. Modern Healthcare 32(23): 8-9
Rosenbaum, S. 1991: GPOs, alliances re-examine waste treatment options. Hospital Material Dollar Sign Management 16(12): 1; 11-12
DeJohn, P. 1998: GPOs, suppliers face off over effects of mergers. Hospital Material Dollar Sign Management 23(11): 1; 9-1,10
Anonymous 2002: GPOs: good or evil? Studies show answer depends on approach of researchers. Hospital Material Dollar Sign Management 27(6): 7-8
Colonna, J. 1998: GPOs: still viable, but their role is changing. Hospital Material Dollar Sign Management 23(9): 12; 19
Wahl, P. 1996: GPR programs: a strategy for admission. Dentistry 16(2): 28-9 32
Zulley, J.; Binnie, C.; Russell, M. 2000: GPS and neurological practice in sleep, headache and epilepsy. Studies in Health Technology and Informatics 78: 15-43
Ota, F.S.; Muramatsu, R.S.; Yoshida, B.H.; Yamamoto, L.G. 2001: GPS computer navigators to shorten EMS response and transport times. American Journal of Emergency Medicine 19(3): 204-205
Stepanek, J.; Claypool, D.W. 1997: GPS signal reception under snow cover: a pilot study establishing the potential usefulness of GPS in avalanche search and rescue operations. Wilderness and Environmental Medicine 8(2): 101-104
Lindsey, J. 2003: GPS, computers, ambulances and getting lost. what do they have in common?. Jems: a Journal of Emergency Medical Services 28(1): 91
Seward, M. 1999: GPT and the profession. General professional training. British Dental Journal 186(6): 261
Susukida, R.; Kido, A.; Oya, M. 1998: GPT genotyping by polymerase chain reaction and restriction fragment length polymorphism analysis. Forensic Science International 98(3): 185-191
Hu, X.; Phillips, G.A. 1999: GPT.EXE: a powerful tool for the visualization and analysis of general processing tree models. Behavior Research Methods Instruments and Computers: a Journal of the Psychonomic Society Inc 31(2): 220-234
Ravanat, C.; Freund, M.; Mangin, P.; Azorsa, D.O.; Schwartz, C.; Moog, S.; Schuhler, S.; Dambach, J.; Cazenave, J.P.; Lanza, F. 2000: GPV is a marker of in vivo platelet activation--study in a rat thrombosis model. Thrombosis and Haemostasis 83(2): 327-333
Merello, M.; Lees, A.J.; Balej, J.; Cammarota, A.; Leiguarda, R. 1999: GPi firing rate modification during beginning-of-dose motor deterioration following acute administration of apomorphine. Movement Disorders: Official Journal of the Movement Disorder Society 14(3): 481-483
Olanow, C.W. 1996: GPi pallidotomy--have we made a dent in Parkinson's disease?. Annals of Neurology 40(3): 341-343
Mitchell, P. 2000: GPnet. go with the flow. Health Service Journal 110(5696): Suppl 16
Bollen, M. 1996: GPs and breast cancer. Australian Family Physician 25(11): 1665-1666
Alexander, T. 2002: GPs and child protection. British Journal of General Practice: the Journal of the Royal College of General Practitioners 52(482): 764-765
Maguire, P.J. 1999: GPs and clinical audit. Medical Journal of Australia 170(10): 507
Stokoe, D.; Ramaiah, S.; Holtby, I. 1992: GPs and contracting for secondary health care. Health Services Management 88(2): 25-26
Cocksedge, S.H. 1993: GPs and counselling. British Journal of General Practice: the Journal of the Royal College of General Practitioners 43(368): 127
Jackson, C.; Hirst, L.; Ambler, J.A.; Battistutta, D. 1997: GPs and eye skills. a brave new world?. Australian Family Physician 26(4): 409
Atkin, N.L.; McInnes, E.C.; Mira, M.; Kennedy, P. 1997: GPs and geriatricians working together. Medical Journal of Australia 167(8): 455-456
Janowski, R.F.; Bhatt, R.; Jenkins, A. 1997: GPs and health authority believe that locality commissioning will improve services. Bmj 315(7109): 681-682
Dicker 1998: GPs and junkies. Bmj 317(7162): 892a
Westerståhl, A.; Segesten, K.; Björkelund, C. 2002: GPs and lesbian women in the consultation: issues of awareness and knowledge. Scandinavian Journal of Primary Health Care 20(4): 203-207
McBride, M.; Colvin, P.; Metcalfe, D.; Jee, M. 1994: GPs and managers. what the doctors saw. Health Service Journal 104(5424): 24-26
MacQueen, A.R. 1998: GPs and methadone. Primum non nocere. Australian Family Physician 27(6): 459-460
Albert, E. 2001: GPs and organisational research. Australian Family Physician 30(10): 930
Gibney, P.J. 1993: GPs and solicitors. Australian Family Physician 22(5): 858-859
Chaney, R. 1997: GPs and the care of people with AIDS. Australian Family Physician 26(7): 835-840
Lakhani, M. 2002: GPs and the information revolution. Bmj 325(7375): 1309
McKay, F. 1993: GPs are best placed to help people stop smoking. Practitioner 237(1524): 272-274
Smith, D.; Scoullar, K. 2000: GPs as 'gatekeepers' for adolescent suicide. Australian Family Physician 29(6): 517-518
Kocken, R.J.; Knottnerus, J.A.; Smeets, P.E. 1993: GPs as participants in scientific research. British Journal of General Practice: the Journal of the Royal College of General Practitioners 43(372): 305-306
Kmietowicz, Z. 2002: GPs asked to do more for drug misusers. Bmj 324(7336): 501
Kenny, C. 1997: GPs behaving badly. Nursing Times 93(11): 14-15
Michiels, B.; Avonts, D.; van Royen, P.; Denekens, J. 2000: GPs can improve their hand washing habits. Bmj 320(7238): 869-870
Nelson, M.R. 2001: GPs can not use randomisation for their own patients. Medical Journal of Australia 174(10): 542; Author Reply 544
Anonymous 1998: GPs can provide thrombolysis faster than hospitals. Bmj 317(7158): e
Clearihan, L. 2000: GPs caring for populations. Australian Family Physician 29(5): 399
Anonymous 1999: GPs could take greater role in care of children with HIV. Bmj 319(7204): e
Warden, J. 1999: GPs criticised by ombudsman. Bmj 318(7179): 282
Dyer, C. 1999: GPs face escalating litigation. Bmj 318(7187): 830
Kmietowicz, Z. 2002: GPs get a new contract "to transform their lives". Bmj 324(7344): 994
Gibbs 2000: Auscultation skills: breath and heart sounds. Bmj 320(7229): 256
Anonymous 1998: GPs giving advice on child safety is effective. Bmj 316(7144): F
Anonymous 2000: GPs in A and E do not prevent reattendance. Bmj 320(7239): e
Spedding, R.; McNicholl, B. 1997: GPs in A&E. Journal of Accident and Emergency Medicine 14(1): 60
O'Neil, J. 1996: GPs in Glasgow are in favour of primary care emergency centres. Bmj 312(7046): 1610
Dobson, R. 2002: GPs in deprived areas do more out of hours work. Bmj 325(7363): 512
Vader 1998: Randomised controlled trials: a User's guide. Bmj 317(7167): 1258
Brooks, P.E. 1993: GPs in partnership with management. Bmj 306(6879): 721
Payne, D. 1999: GPs loth to report child abuse. Bmj 318(7177): 147
Anonymous 1998: GPs management decisions are influenced by patients' social problems in 17% of consultations. Bmj 317(7150): D
Fox, B. 2001: GPs need guidance on protecting their computers from viruses. Bmj 323(7317): 870
Anonymous 1999: GPs need models for managing bereavement. Bmj 319(7205): G
Holmes, B. 1998: GPs need open-access spirometry in COPD. Practitioner 242(1584): 153
Cowap, N. 1996: GPs need to be more proactive in providing health care to teenagers. Bmj 313(7062): 941
Anonymous 2000: GPs need to critically appraise evidence before adopting it. Bmj 320(7242): F
Bindman, J.; Beck, A.; Thornicroft, G. 1997: GPs need training in care programme approach more than in supervised discharge. Bmj 315(7099): 61-62
Bain, S. 1996: GPs need training to treat survivors of abuse. Australian Family Physician 25(7): 1179-1180
Bunce, C. 1996: GPs negotiate payment for nursing home patients. Bmj 313(7066): 1163
Irwin, D.; Miller, J.M.; Cornell, S.J. 1996: GPs often fail to give early parenteral benzylpenicillin in suspected meningococcal infection. Bmj 312(7045): 1538
Tattersall 1999: Informing patients: An assessment of the quality of patient information materials. Bmj 318(7196): 1494
Wilcock, M.; Mackenzie, I. 2001: GPs prescribing specialist medicines. British Journal of General Practice: the Journal of the Royal College of General Practitioners 51(468): 585
Campbell 2000: Generations at risk: reproductive health and the environment. Bmj 320(7241): 1082
Anonymous 1999: GPs should be balloted on primary care trusts. Bmj 319(7213): 858
Ferriman 1999: GPs should give reasons for removing patients from lists. Bmj 318(7194): 1309b
Kelly, G.S. 1999: GPs should not connect to NHSnet until it is restructured. Bmj 318(7182): 533-534
Mahmood, A. 2000: GPs should not hand out medication indiscriminately to people with learning disabilities. Nursing Times 96(2): 35
Clarke, J.; Giles, M.; Peck, E. 2000: GPs should take hold of mental health agenda. Bmj 321(7273): 1414
Chaudhry, S. 2002: GPs should use nurses more to lighten their load. Bmj 325(7355): 62b
Kmietowicz, Z. 2001: GPs shut surgeries in protest at government targets. Bmj 322(7294): 1082
Poyner, T. 1998: GPs step into the breach. Practitioner 242(1585): 241
Adams, P. 2000: GPs take stock. Use it or lose it!. Australian Family Physician 29(1): 7-10
Anonymous 1998: GPs tend to report only serious reactions to new drugs. Bmj 317(7151): D
McKenna, C. 2002: GPs vote "yes" for new contract framework. Bmj 325(7356): 119
Beecham 2000: GPs want self regulation to continue. Bmj 320(7251): 1692b
Anonymous 1999: GPs want to keep generalist role in genetic testing. Bmj 319(7222): G
Anonymous 1999: GPs want walk in centres piloted properly. Bmj 318(7191): 1149
Sheldon, T. 2001: GPs warned on accepting hospitality from drug companies. Bmj 322(7280): 194
Warden, J. 1997: GPs will be at heart of overhaul of NHS. Bmj 315(7119): 1331
Anonymous 1999: GPs will set up an english committee. Bmj 318(7184): 675
Poyner, T.F. 2002: GPs with special interests. British Journal of General Practice: the Journal of the Royal College of General Practitioners 52(484): 943
Heikkinen, M.; Pikkarainen, P.; Eskelinen, M.; Julkunen, R. 2000: GPs' ability to diagnose dyspepsia based only on physical examination and patient history. Scandinavian Journal of Primary Health Care 18(2): 99-104
Morris, C.J.; Cantrill, J.A.; Weiss, M.C. 2001: GPs' attitudes to minor ailments. Family Practice 18(6): 581-585
McGillion, J.; Wanigaratne, S.; Feinmann, C.; Godden, T.; Byrne, A. 2000: GPs' attitudes towards the treatment of drug misusers. British Journal of General Practice: the Journal of the Royal College of General Practitioners 50(454): 385-386
Kennedy, I.; Williams, Sân.; Reynolds, A.; Cockcroft, A.; Solomon, J.; Farrow, S. 2002: GPs' compliance with health and safety legislation and their occupational health needs in one London health authority. British Journal of General Practice: the Journal of the Royal College of General Practitioners 52(482): 741-742
Robinson, G. 1998: GPs' continuing medical education. British Journal of General Practice: the Journal of the Royal College of General Practitioners 48(437): 1871
Leung, W.C. 2000: GPs' diagnosis of dementia. British Journal of General Practice: the Journal of the Royal College of General Practitioners 50(457): 666
Morgan, M.; McKevitt, C.; Hudson, M. 2000: GPs' employment of locum doctors and satisfaction with their service. Family Practice 17(1): 53-55
Ward, J.; Girgis, S. 1999: GPs' estimates of men's risk of prostate cancer and screening expectations. Australian and New Zealand Journal of Public Health 23(2): 219-220
De Bock, G.H.; Vliet Vlieland, T.P.; Hakkeling, M.; Kievit, J.; Springer, M.P. 1999: GPs' management of women seeking help for familial breast cancer. Family Practice 16(5): 463-467
Aaraas, I.; Fylkesnes, K.; Førde, O.H. 1998: GPs' motives for referrals to general hospitals: does access to GP hospital beds make any difference?. Family Practice 15(3): 252-258
Dick, M.-L.; Schluter, P.; Johnston, C.; Coulthard, M. 2002: GPs' perceived competence and comfort in managing medical emergencies in southeast Queensland. Australian Family Physician 31(9): 870-875
Stevenson, F.A.; Greenfield, S.M.; Jones, M.; Nayak, A.; Bradley, C.P. 1999: GPs' perceptions of patient influence on prescribing. Family Practice 16(3): 255-261
Carr, J.; Armstrong, S.; Hancock, B.; Bethea, J. 2002: GPs' perceptions of the nurse practitioner role in primary care. British Journal of Community Nursing 7(8): 408-413